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Background  
The cellular components of the human body, from a single cell to a cluster of cells in 
a complex organ, need to be embedded in fluid to maintain proper and precise 
functionality. The fluid within the human body accomplishes many tasks whether in 
its involvement with intracellular communication, removal of waste products or 
supply of nutrients to the tissue. Any disturbances in interstitial fluid homeostasis 
may lead to organ dysfunction, and can even be fatal. Fluid balance and composition 
of body fluids in different compartments are strictly regulated to ensure stability in 
response to fluctuations in the outside environment. Powerful control mechanisms 
within the kidneys and endocrine and autonomic nervous systems help to maintain a 
relatively constant volume and stable composition of body fluids. Due to the 
complexities of the constant fluid flux among the different compartments of the body, 
microcirculatory and capillary-interstitial fluid exchange have been topics of 
particular interest for many decades. Continuously improving knowledge of fluid 
balance by studying the forces that act on the walls of capillaries and by examining 
structures connected to fluid and protein transport can enhance our comprehension of 
fluid physiology further.  
Existing information on fluid balance has been derived from research on cell cultures, 
animal models, human clinical trials, and from clinical experience, together with 
theoretical knowledge on fluid balance and therapy. In humans, what we currently 
know about fluid balance is partly based on studies of adults rather than children, 
leaving an unfilled gap in knowledge about fluid dynamics from the period covering 
birth to late childhood1-3. The reason for this lack of knowledge is not due to a failure 
in realising the importance of fluid balance in the paediatric population, but due to 
difficult, suitable methods to study fluid dynamics in this population and stringent 
research legislation safeguarding children. The strictly regulated laws concerning 
paediatric clinical research are meant to protect a vulnerable population incapable of 
protecting their own interests and therefore to avoid potentially harmful and 
unnecessary incidents4. The Norwegian Health Research Act upholds these laws but 
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grants permission for clinical research under certain conditions5. Several unanswered 
questions remain about fluid balance in children but can now be more safely 
addressed within the framework of current laws and ethics.  
This thesis highlights important clinical issues concerning fluid balance in children. 
Classic physiological methods were employed, and the research was conducted with 
close cooperation between basic research and clinical practice. Furthermore, the 
thesis includes results from studies that may provide new insight into the mechanisms 
of fluid regulation across the lifespan. These studies propose the adoption of new 
values for colloid osmotic pressure in healthy children that may enable clinicians to 
readily recognise pathological processes involved in vascular regulation in conditions 
in which tissue fluid retention occurs. 
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Abstract 
Objective: The capillaries represent a semipermeable barrier between the blood and 
the interstitium, where there is a continuous exchange of fluid and solutes. Numerous 
factors affect the tight regulation of this movement across the microvasculature, with 
transmural pressure gradient being a key element governed according to the Starling 
equation. Colloid osmotic pressures, acting on both sides of the capillaries, are one 
class of forces defining the movement of fluid between the capillaries and interstitial 
spaces, and these are influenced by age, maturation, health, and disease. There is 
limited knowledge on the capillary-interstitial exchange in children that favours 
extravasation of fluid. Our understanding of paediatric fluid balance is to a certain 
extent based on practical experience, observation, and extrapolation of data obtained 
in the adult population, rather than on precepts or theory. The studies included in this 
thesis work were aimed at evaluating a method for sampling subcutaneous interstitial 
fluid, studying the interstitial and plasma colloid osmotic pressure in the paediatric 
population, and at gaining a better understanding of local inflammation during 
asphyxia, in paediatric subjects. 
Methods and Results: In healthy adults, the colloid osmotic pressure of subcutaneous 
fluid sampled by implanted nylon wicks was similar to that reported in previous 
studies using other sampling methods. Comparing plasma and interstitial fluid using 
high performance liquid chromatography excluded the possibility of contamination 
with haemoglobin and other macromolecules in wicks, and indicates that this 
sampling method is only mildly traumatic. Colloid osmotic pressures obtained from 
saline-soaked wicks implanted for different time periods indicate that an optimal 
implantation time is between 75-90 minutes. There was no significant difference in 
colloid osmotic pressures obtained by dry or wet nylon wicks. Interstitial colloid 
osmotic pressure also did not differ for implantation times of 60 or 90 minutes in 
children. Sixty minutes of topical application of anaesthetic cream before insertion of 
wicks reduced the pain experience, and did not influence colloid osmotic pressure. 
This result argues that wicks could likely be used reasonably in the paediatric 
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population. Boys and girls between 2 and 10 years old had colloid osmotic pressure 
in plasma similar to that measured in adults, showing increasing age-specific values 
for interstitial and plasma colloid osmotic pressure. The altered colloid osmotic 
pressure gradient that occurs during the ages of 2 to 7 years may facilitate fluid 
transport into the capillaries and reduce lymphatic absorption for the purpose of 
preserving homeostasis. The colloid osmotic pressure gradient for asphyxiated 
neonates was unaltered throughout therapeutic hypothermia treatment, showing 
decreased interstitial and plasma colloid osmotic pressure compared to healthy-term 
neonates. Cytokine levels during therapeutic hypothermia, as measured by magnetic 
bead immunoassay, were elevated for IL-1α in tissue and reduced in serum for IL-
1RA, IL-6, IL-8, and IL-10, suggesting a balanced inflammatory stimulus. This is 
underscored by a decreased white blood cell count, which is known to be beneficial 
for recovery after brain injury. 
Conclusions: The wick method is a feasible method for sampling native interstitial 
fluid in adults and is now demonstrated to be applicable also in children, if performed 
with topical anaesthesia. Implantation times of 60-90 minutes are sufficient for 
sampling fluid in both adults and children to avoid cellular inflammation due to 
implantation trauma. The optimal harvesting time within this time frame is uncertain. 
Asphyxiated neonates have lowered interstitial and plasma colloid osmotic pressure 
and reduced colloid osmotic pressure gradient, which may be a normal physiological 
and beneficial response to therapeutic hypothermia treatment, combined with an 
overall immunosuppressive effect. The finding of comparable colloid osmotic 
pressures in children between 2 and 10 years of age and in adults, and for infants over 
2 months of age, suggests a change occurs as part of the circulatory transformations 
that take place after birth. 
 9 
List of publications 
This thesis is based on the following papers, which are referred to in the thesis by the 
Roman numerals listed here. 
I. Guthe HJ, Nedrebo T, Tenstad O, Wiig H, Berg A (2012)  
Effect of topical anaesthetics on interstitial colloid osmotic pressure in human 
subcutaneous tissue sampled by wick technique 
PLoS One 7(2): e31332 
II. Guthe HJ, Indrebø M, Nedrebo T, Norgård G, Wiig H, Berg A (2015) 
 Interstitial fluid colloid osmotic pressure in healthy children 
 
PLoS One 10(4): e0122779 
 
III. Guthe HJ, Nedrebo T, Wiig H, Berg A (2015) 
Transcapillary fluid flux and inflammatory response during neonatal 
therapeutic hypothermia: an open, longitudinal, observational study 









CFC   Capillary filtration coefficient  
COP  Colloid osmotic pressure 
COPif  Interstitial colloid osmotic pressure 
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Nå er vi i slutten av en deilig sommer, 
og slutten er alltid at noe annet kommer. 
Så da er vi igjen, midt i begynnelsen… 
deLillos, Vakre dager, Midt i begynnelsen, 2002 
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1. Introduction 
The normal cell is a highly complex unit in which the various organelles and enzyme 
systems continuously carry out metabolic activities that maintain cell viability and 
support its normal functions. The normal function of cells largely depends on the 
integrity of the interstitial tissue that makes up the immediate microenvironment of 
the cell. Interstitial tissue is composed of cells, water, electrolytes, ground substances 
and fibrillary elements. Transport of ions, nutrients and waste products (metabolic 
substrates) in the extracellular fluid is life supporting for cellular functions and 
reproduction. This internal environment or ‘milieu intérieur’ was already described in 
the mid-eighteenth century by the French physiologist Claude Bernard6. Dr Berhard 
described in his lectures from 1857 how the human organism tries to maintain 
equilibrium of body fluids for optimal function, in other words, homeostasis.  
1.1 Body water and its compartments 
Total body water (TBW) comprises almost 60% of the body weight of an adult man 
and is distributed between the intracellular and extracellular space. These spaces are 
separated by a cell membrane, across which the composition of the two fractions are 
very different7. The extracellular fluid is distributed in the interstitial compartments 
and plasma, separated by the capillary wall, and is thought to be approximately 33% 
of TBW. The typical adult human has an extracellular volume of 15 litre, for which 
plasma volume represents 3 litre8. The total water content in the body varies 
considerably, according to a number of factors such as gender, age, and content of 
body fat. Since TBW, as a per cent of body weight, will decrease with increased body 
fat9, a hypothetical adult female will contain about 50% of her body weight as water. 
This lower percentage is due to a higher body fat content. Interestingly, longitudinal 
studies indicate a concurrent increase in body water volume with increasing epidemic 
obesity and overweight together with an enlarged proportion of extra cellular water to 
TBW10.  
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In the foetus, TBW, together with extracellular fluid, declines during pregnancy. By 
contrast at term, intracellular fluid comprises approximately one half of TBW, the 
latter presumably reflecting cellular growth and accretion of protein and minerals in 
addition to accumulation of body fat11. At birth 75-80% of body weight is represented 
as TBW, a percentage that rapidly declines during the first 12 months. A more stable 
level is reached before 3 years, and around 9-10 years of age, a TBW similar to that 
of an adult individual is achieved12 (Figure 1). Regardless of technique used for foetal 
or neonatal measurement, reported variations in proportions of TBW are small 
amongst various studies13. The brisk reduction of TBW and ensuing foetal weight 
loss in newborns is normally 5-10% of body weight14, increasing to 15% in premature 
infants15. The neonatal weight loss can be partially explained by a loss of 
extracellular fluid, which is greater than the increased volume of intracellular water. 
Although this phenomena is not fully understood, this may be due to the physiologic 
cardiopulmonary adaptation that occurs postpartum16, 17 and to postnatal diuresis, 
together with a brief negative net water and sodium balance occurring after birth18-20. 
The reduction of TBW throughout childhood is therefore primarily due to a gradual 
decrease of extracellular water content from approximately 40% of body weight in a 
neonate to 20% at puberty11. With advancing age, muscle mass is reduced and fatty 
tissue may be increased by 5-10%. This fatty tissue increase is associated with a 










Figure 1. Variation in body water volume with increasing age. (Redrawn from 
Barsness23) 
From a functional and clinical point of view, total body fluid volume can be roughly 
thought of as being divided into two separate compartments, the extracellular fluid 
volume (ECV) and the intracellular fluid volume (ICV). ECV accounts for one-third 
of TBW (20% of body weight), and ICV accounts for two-thirds of TBW (40% of 
body weight)7(Figure 2). With increased muscle mass occurring during puberty in 
males, their ICV will be typically greater than that of females. A small fraction of 
volume, called transcellular fluid, includes the volume contributed by the 
cerebrospinal fluid and synovial fluid. Transcellular fluid has features and content 
that differs from ECV and ICV and normally represents less than 3% of all body 
fluids24. Solute composition in ECV and ICV differs. While potassium and 
magnesium are the major cations and proteins and organic phosphates are the major 
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anions in ICV, the major cation and anions of the ECV are sodium and chloride, 
respectively, together with the anion, bicarbonate. Cellular ATPase is involved in 
maintaining this asymmetric transmembrane distribution of cations, in which net flux 
of water is driven by ECV osmolality. The plasma and interstitial fluid (IF) accounts 
for 25% and 75% of ECV, respectively. The dynamic exchange of fluid between the 
plasma and interstitial spaces takes place across the capillary membranes and depends 
on its permeability properties, restricting protein access to the IF. As a result, IF and 
plasma will have a similar ionic composition, although plasma will normally contain 
a higher protein concentration than IF. IF, then, is engendered properties of a fluid 
buffer in the body, serving to maintain proper fluids and volume in the intravascular 
space7. The plasma volume represents about 5% of body weight in all age groups 












   
















1.2 Macro, - and microcirculation 
The circulatory changes during birth represent a change from aquatic to terrestrial 
life. Clearance of water from the lungs with a concomitant rapid decrease in 
pulmonary vascular resistance allows increased pulmonary blood flow to fill the left 
atrium and close the foramen ovale. Obstruction of the intra-atrial connection, in turn, 
increases left ventricular preload almost simultaneously with cardiac output, a series 
of events that normally terminates foetal circulation. Due to the increasing systemic 
pressure over the previous placental pressure (which is lower), systemic vascular 
resistance rises after birth and is followed by a gradual decrease within the first five 
years of life. Both stroke volume and cardiac output gradually increase to meet 
increasing metabolic needs26.  
Although maintenance of blood flow throughout the body is accomplished by the 
macrocirculation and is vital for homeostasis, functional auto regulation of 
microcirculation and organ perfusion is a prerequisite for this to happen. Analysing 
tissue perfusion, and hence the microcirculation, is possible by means of different 
imaging techniques, like orthogonal polarization spectral imaging and sidestream 
darkfield imaging, in which microcirculatory variables are measured by a handheld 
optical device.27, 28. Two parameters defining the microcirculation are: (1) functional 
capillary density (FCD) that serves as a marker of tissue perfusion and (2) 
microvascular flow index (MFI), a measure of convective flow29. FCD in buccal 
mucosa in neonates younger than 7 days is significantly greater compared to FCD in 
later infancy. This is related to postnatal adaptation, with initial increased cardiac 
output partially due to, in general, elevated oxygen consumption, temperature control, 
and stimulation of gastrointestinal function30. This is in line with similar changes in 
skin found in premature babies, suggesting a correlation with circulatory transition 
after birth rather than advancing age31. A low FCD during disease suggests that tissue 
perfusion is reduced, and is exemplified by tenacious depressed FCD in children 
suffering from septicaemia, which has a pessimistic outcome29. Similarly, a decrease 
in axillary microcirculatory blood flow accompanied by lower MFI during 
therapeutic hypothermia (TH) is reversed after rewarming in neonates suffering from 
 19 
asphyxia32. Whether the reduced tissue perfusion is due to partially microvascular 
shut down (lowered capillary hydrostatic pressure (Pc)) or to hyperviscosity (as seen 
in TH) is unknown.  
The vessels that permit exchange of fluid and nutrition between cell and blood are 
part of the microcirculation. These consists primarily of capillaries less than 10 µm in 
diameter7. The capillaries, composed of a unicellular layer of adjacently packed 
endothelial cells (EC), are encircled by a basement membrane and interspersed by 
infrequently positioned smooth muscle cells. ECs function as ‘gatekeepers’, allowing 
fluid to pass across overlapping intercellular junctions that act as pores between 
endothelial cells (paracellular route)33. These pores can function as signalling 
complexes that communicate cell position, growth, and apoptosis, and thus regulate 
vascular homeostasis34. Therefore, EC junctions have different characteristics, 
depending on the target organ and its specific needs. Thus, the endothelium of 
capillaries can be characterised by plasticity and heterogenic phenotypes35. The 
continuous non-fenestrated endothelium, with ‘tight and narrow’ junctions, allows 
only small molecules and water to pass, and is localised to brain, heart, skin, and lung 
tissue. On the contrary, a discontinuous/sinusoidal endothelium found in liver, bone 
marrow, and spleen permits nearly all dissolved substances, including proteins, to 
pass relatively freely. Continuous, fenestrated endothelium has openings throughout 
the cell layer, which allows vast amounts of fluid and solutes to pass freely, holding 
back only large plasma proteins. Peritubular renal capillaries, choroid plexus, 
intestinal and gastric mucosa capillaries, and glands contain this type of 
endothelium7.   
At a more macro level, the vascular tree is made up of different classes of vessels, 
continuously patterned and remodelled according to the functions of specific organs. 
Endothelial heterogeneity across the organs is greatly influenced by epigenetic 
factors. New insight into vessel maturation and differentiation, pre- and postnatal, 
reveals that haemodynamic forces36, 37 (pressure and flow) and presence/absence of 
hypoxia38, 39 are important determinants for the continuous development of 
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components of the vessel wall (i.e., endothelium, smooth muscle and extra-cellular 
matrix).  
1.3 The lymphatic system 
The lymphatic system is closely connected to the terminal part of the microcirculation 
and covers almost all tissues of the body except for the epidermis and cartilage. IF, 
proteins, immune cells, and other solutes of high molecular weight derived from the 
arterial end of the blood capillary circulation are absorbed by the lymphatic 
capillaries and returned to the blood through the lymphatic system. The network of 
lymphatic vessels therefore guide the immune cells to the lymph nodes, which is 
important for adaptive and innate immune response in addition for preserving fluid 
homeostasis and tissue proteostasis40.  
The endothelial cells of the lymphatic capillaries are of different morphological 
composition than blood vessels, because their function is different from blood 
vessels41. Absorption by lymph is possible because terminal lymphatic vessel walls 
have spontaneous and stretch-activated vasomotion (lymphatic smooth muscle cells), 
which serves as ‘pumps’ that favour transport through the lymphatic system. Lymph 
is emptied into the large veins, accounting for a lymph flow of 120 ml/hour or 2-3 
litres/day returned7, 42. This is about one-tenth of all fluid filtered by the capillaries.  
There are major differences in basal lymphatic function between the foetus and 
adult43. For example in newborn lambs, increased lymph flow occurs as a response to 
fluid expansion44, potentially serving as an oedema defence mechanism45. It is 
generally accepted that lymph entering the lymphatics has a composition similar to 
IF, and that sampling of lymph from the lymphatics, or at a point after the lymph 
nodes, differs in its protein composition, the latter being increased46. Probably more 
important for lymph flow is the hydrostatic pressure within the interstitium, which 
generates a positive lymph flux. Sub atmospheric pressures down to -6 mmHg has 
been demonstrated in the leg of a dog7. Interstitial pressures are slightly 
subatmospheric or close to atmospheric and when increased there is a concomitant 
rise in lymph flow8. Interestingly, a rise in interstitial pressure to the level of 
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atmospheric pressure generates almost a 20-fold increase in relative lymph flow, and 
then when the threshold for maximum lymph flow rate is exceeded, oedema will 
occur (called exceeding the oedema safety factor).  
Beside interstitial pressure and the lymphatic ‘pump’, external intermittent 
compression of the lymphatics favours lymph propulsion42. This compression occurs 
during contraction of surrounding skeletal muscle, body movement and gravity, 
pulsation of adjacent arteries, and external compression of the body. Additionally, 
filaments that anchor the walls of lymphatic endothelial cells to the surrounding 
tissue will stretch with increased IF, facilitating a flux of fluid into the lymphatics8. 
Since the volume of IF is inextricably tied to a rise in interstitial pressure, the lymph 
flux in the initial lymphatics will be affected by compliance (see 1.4 Transcapillary 
fluid exchange) of the interstitium defining the interstitial pressure. The lymphatic 
system is therefore a primary determinant of IF pressure, volume of IF, and protein 
concentration of IF.  
1.4 Transcapillary fluid exchange  
Fluid exchange across the capillaries is possible by either diffusion or filtration. 
Diffusion according to Fick’s law states that fluid moves from a region of high 
concentration to a region of low concentration, having a magnitude that is 
proportional to the concentration47. Since the capillaries consist of a single 
endothelial layer, bidirectional transport of fluid across such a semipermeable 
membrane is considered to be a passive phenomenon, and transport of solutes 
depends on the chemical and physical properties of the properties35, 48. This is called 
ultrafiltration. Filtration, on the other hand, results in a net movement of water that 
occurs because of an imbalance between the forces promoting outward flow and 
forces promoting inward flow.  
Ernest Starling postulated in 1896 that fluid movement related to filtration across a 
capillary wall depends on the balance between the hydrostatic pressure gradient and 
the colloid osmotic gradient across the capillary wall49. This theorem has been 
reviewed many times, referred now to as the “Starling hypothesis”50. It was later 
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expressed formally in the Starling equation40 (Eq. 1), in which transcapillary transport 
of fluid (Jv) is determined by the difference between hydrostatic pressure (P) and 
colloid osmotic pressure (COP). The balance of these forces allows calculation of the 
net driving pressure for filtration. 
Eq. 1.  Jv = CFC ((Pc-Pif) -σ (COPP-COPif)) = CFC x ΔP = flow of lymph 
 
 
Figure 3 Pictorial representation of the numerical variables of the Starling equation 
involved in extravasation of fluid. Modified from Wiig et al51  
The capillary filtration coefficient (CFC) is the product of capillary hydraulic 
permeability (Lp) per unit surface area and the available area (S) 52,53.  It varies 
amongst the different vascular beds54 (i.e., intestine versus skeletal muscle). Capillary 
hydraulic permeability per unit surface area is often referred to as the hydraulic 
conductance, which is a measure that describes the efficiency at which water crosses 
the capillary wall. It follows from Eq. 1 that CFC is a proportional factor related to a 




can be handled by the lymph, but CFC by itself cannot prevent an increase in 
interstitial volume. CFC is presumed to be constant under different fluid pressures in 
the same area, given steady state conditions8. However, it reportedly shows a 
moderate increase with systemic low-grade inflammation55, and gradually decreases 
in situations of elevated transmural pressure, for example, in the arm or leg, where 
local vascular response tends to limit excessive filtration 56. 
Pc-Pif is the difference in hydrostatic pressure between the capillaries (c in Pc drives 
filtration) and IF (if in Pif partially counteracts filtration), while COPP-COPif is the 
correlating difference in colloid osmotic pressure, where p is plasma. The value of Pc 
is highly variable and depends on tissue type and physiological conditions. It is the 
most variable amongst the pressures in Eq. 1.57. Pc is influenced by distance along the 
microvasculature, microvascular resistance, arterial (Pa), and venous pressure (Pv), 
together with gravity. Since Pc must be between Pa and Py, the effect of pre- and post-
capillary resistance (Ra and Rv, defining the ratio of Ra /Rv), together with an 
alteration in arterial and venous pressure, defines its magnitude7. Increments in either 
Pv or Pa will raise Pc, but an increase in Pv in humans is almost five times as effective 
as the same change in Pa in altering Pc58. This is due to the moderately low venous 
resistance, in which a change in Pv readily is transmitted back to the capillary. 
Conversely, a relatively high arterial resistance will not conduct a similar change in 
Pa downstream, in which the capillary lowers the Pc. Therefore, acute inflammation 
accompanied by local heat production elicits arteriolar vasodilatation, which lowers 
the pre- to post-capillary ratio and, consequently, raises Pc, favouring filtration to the 
interstitium58. Conversely, arteriolar vasoconstriction after severe bleeding, for 
example, elevates this ratio and lowers Pc. This results in a greater value for COPp, 
which favours absorption of fluid from the interstitium. Pif is marginally 
subatmospheric in the skin of an adult, given a relative state of interstitial 
dehydration. This occurs by a small net capillary filtration pressure and removal by 
lymph8.  
The plasma colloid osmotic pressure (COPp) in human varies for some age ranges. 
While children and adults have almost identical values of 25 mmHg for COPp59, 60, it 
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is reduced in younger ages61, being approximately 19 mmHg62 and 15 mmHg63 for 
term and preterm babies, respectively. It is the plasma proteins that drive plasma 
colloid osmotic pressure, and albumin is responsible for 80% of COPp. Large 
molecular mass and net negative charge (Gibbs-Donnan effect) define its oncotic 
property64. The IF colloid osmotic pressure (COPif) varies in different tissues and 
under different conditions (between 30-60% of plasma COP), and has been the 
subject of much debate because different methods for harvesting interstitial fluid have 
been used to determine its true value40, 57, 65.  
IF is traditionally sampled some distance from the capillary, and according to Levick 
and Michel40, the measured COPif may not exert the relevant pressure for capillary 
fluid exchange. The measured COPif may rather reflect a global COPif. A lower COP 
close to the barrier of filtration, namely the COP of the glycocalyx (COPg) creates a 
higher COP gradient (COPp – COPif < COPp – COPg), which in turn determines the 
fluid balance (Figure 4). A lower COP close to the barrier of filtration may result 
from the ever-present fluid filtration and dilution of proteins. In vivo studies in rats 
and frogs indicate that this oncotic transcapillary pressure gradient depends on 
filtration rate, with a global COPif close to COPg near the endothelial border under 
normal filtration pressures66, 67. With capillaries filtering plasma at a high rate, the 
anticipated increase in filtration due to elevated COPif may be absent, but can be 
explained by a COPg approximating 10% of COPif. Wiig and Swartz have recently 
extensively reviewed this relation, concluding that ‘COPif as determined in global IF 
is still a major determinant of normal fluid filtration’46, all in line with COPif 

















Figure 4. Schematic model illustrating how the effective oncotic pressure in a 
capillary arises; πc, πg, and πt are the colloid osmotic pressure of the capillaries, the 
glycocalyx, and the interstitium, respectively. Pc and Pt define hydrostatic pressure in 
the capillaries and IF. From Wiig and Swartz, with permission46 
Sigma (σ) is the capillary reflection coefficient for macromolecules and proteins 
(ranging from 0 and 1), in which an impermeable barrier will have σ = 1, and σ = 0 if 
the barrier freely allows passage of proteins. Under steady-state conditions, the net 
filtration of fluid across the semipermeable capillary membrane is balanced by 
corresponding lymph drainage, and Jv will equal the flow of lymph, which in turn 
secures steady hydration of tissue. Fluid filtered out from the capillaries and 
reabsorbed within its proximity is estimated to be 18-27 litres/day7. During 
inflammation, the disruption of the endothelial barrier will change protein 
permeability and hence reduce the reflection coefficient for proteins causing oedema. 
ΔP is the net pressure gradient across the capillaries and is estimated to be between 
0.5-1.0 mmHg8 which leads to a net fluid filtration, but this is removed by the lymph 
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flow. IF volume and plasma volume will therefore be influenced by changes in 
colloid osmotic pressure, hydrostatic pressure and flow of lymph. These three 
dynamic parameters must greatly affect each other in order to obtain normal 
regulation or autoregulation8 of the IF volume. Although the intravascular forces (Pp 
and COPp) are far excessive than the extravascular forces (Pif and COPif) (Eq. 1.), the 
Pif and COPif are comparable in magnitude to the difference between Pc - COPp57, and 
therefore may significantly affect the net transcapillary fluid flux.  
Hydration of organic matter will normally result in tissue distension. The ability of a 
certain tissue to resist these changes defines its compliance, and can be expressed as 
the alteration in interstitial volume due to a corresponding change in IF pressure 
(ΔIF/ΔPif). Different tissues have different compliance and consequently, the low 
compliant tissue will oppose expansion, showing a distinct increase in Pif, even at 
small increments in volume. By contrast, highly compliant tissue may display a 
considerable volume increase before Pif rises. Compliance is also prone to change 
over time due to stress relaxation. This is exemplified by high compliance in chronic 
overhydration due to secondary lymphoedema68. Composition, change of interstitial 
content, tissue architecture, and tissue organisation define the compliance and are 
influenced by both acute and chronic modulation, such as injury, inflammation, and 
tissue remodelling46.  
Impaired fluid regulation and subsequent swelling of tissue can result from increased 
capillary hydrostatic pressure or lowered plasma colloid osmotic pressure, resulting 
in increased transcapillary fluid flux, or result in reduced drainage of lymph58. In 
human subcutis, visible oedema appears with increments of 50-100% in IF volume, 
with Pif being at a slightly atmospheric levels52. An overall increased net movement 
of water with a raised interstitial pressure and/or lowered interstitial COP was first 
described by Guyton et al. as, ‘oedema preventing mechanisms’69. Disturbing this 
delicate balance of exchange between IF and blood may have profound effects on the 
human body, and both age-related differences in COP and P, as well as homeostasis 
or sickness, may influence its outcome. 
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1.5 The endothelial luminal surface: glycocalyx component 
The endothelial glycocalyx (EG) is a multicomponent luminal network of membrane-
bound proteoglycans and glycoproteins that cover ECs70. Various plasma components 
incorporate within the EG. A continuous and dynamic equilibrium is present between 
flowing blood and soluble and bound contents of the EG that continuously affects its 
extensiveness and composition. Increased vascular diameter appears to increase the 
thickness of the EG71. The EG has a slightly negative electrostatically charged surface 
and is involved in many functions, including being a messenger for almost all 
endothelial tasks, adhesion, permeability, mediation of shear stress, and inflammatory 
processes72.  
The EG serves as a barrier for unintentional adhesion to the vascular wall by 
leukocytes or platelets. The intact EG hides adhesive molecules and sheds leukocytes 
before they adhere, thereby protecting the endothelium73. This coincides with a potent 
proinflammatory stimulus, followed by degradation of the EG and releasing the 
degraded products into the circulation. Also, chronic inflammation and acute injury 
signalling have been linked directly to glycocalyx functions, being one of the earliest 
sites for detection of inflammatory mediators. Detection alters glycocalyx structure 
and function71. In pathological conditions like cardiovascular and 
ischemia/reperfusion disease, the EG is impaired, resulting in changes in 
permeability74. Studying the mesenteric capillaries of rat, Yen et al. found that 
interrupted or distorted blood flow, which alters the EG, changes regulation of 
endothelial nitric oxide (NO) synthase and thus vascular NO production; this is 
accompanied by loss in vascular tone75. The EG therefore seems to serve as 
mechanical sensor and a transducer of blood flow. Endothelial permeability in rat 
myocardial capillaries, for example, is greatly increased when EG thickness is 
reduced, leading to oedema. This cannot be explained by the reduction in EG size or 
steric hindrance alone76. Also, a less negatively charged EG due to glycocalyx 
degradation occurs with increased protein uptake by ECs, promoting oedema71.  
 28
Little is known about EG composition in younger ages, but it seems that senescence 
of endothelial cells in cell culture increases traction forces through age-related 
changes in the glycocalyx77. The effect on the COP gradient contributed by the 
glycocalyx was discussed in the previous chapter.  
1.6 The interstitium 
The space between cells and capillaries is called the interstitium and is surrounded by 
IF8. The interstitium and the IF reside in the extracellular matrix (ECM) 78. 
Composition of the interstitium differs in different tissues, as does the amount of wet 
tissue weight IF, ranging from 10 to 50%46. The interstitium is not solely a passive 
conduit for fluid transport. The complex structure of the constituents of the 
interstitium allows each constituent to continuously interact with each other, 
providing a homogenous fluid environment for the surrounding cells, storage of 
energy, structural support, and cell-to-cell communicating pathways.  
In general, the interstitium is made up of glycosaminoglycans (GAGs) and collagens 
mixed with elastin in a gel phase of proteins and electrolyte-rich fluid. These are 
passed through the capillary wall and thus reflect the actual capillary membrane 
characteristics (i.e., the ultrafiltrate of plasma). Together, the collagens consist of 
three polypeptide (α) chains79 and are classified according to function and type of 
homology (there are at least 28 different types of vertebrate collagens)80. Beside 
supporting tensional strength and scaffolding different tissues due to the reduced 
ability to expand8, collagen participate in cell communicating and alter paracrine 
functions through trans membrane collagens80. Cells within the matrix itself mainly 
produce the content of the ECM, and collagen and elastin are secreted by fibroblasts, 
which are the major connective tissue cell type.   
The two main types of GAGs (non-sulphated and sulphated GAGs) are coiled, 
complex carbohydrate molecules surrounded by a shell of water molecules that have 
massive hydrodynamic volume in aqueous solutions81; these can differ in size 
because of tissue hydration. Compared to the almost electro-neutral collagen, GAGs 
are negatively charged and are partly the reason for the negative charge of the 
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interstitium-attracting counter ions that are responsible for hydration of the ECM by 
osmosis52. Also, both GAGs and collagen are space-occupying masses, which trap 
plasma proteins, preventing them from mixing with all IF and allowing for a small 
free-fluid phase. This is called steric exclusion and may amplify the COPif in less 
hydrated GAGs46. This effect may influence collagen matrix deposition in vitro. A 
balanced COP of GAG and free fluid in the IF are thought to reflect COPif46.  
Other glycoproteins, such as fibronectin, laminins, and matricellular proteins, are part 
of the ECM and function as either structural components or regulatory molecules82. 
The interstitium is also a reservoir for other ECM components. Different growth 
factors are induced by a wide array of processes in the ECM and may signal 
synergistically with integrins83. Integrins are transmembrane receptors anchoring 
collagen fibres to cells, bridging cell-to-ECM interactions. Using an integrin-deficient 
mouse model, Svendsen et al. linked reduced collagen contraction with lowered IF 
pressure, supposedly occurring through hydration of GAGs and concomitant 
development of oedema84. Beside ‘wash out’ of structural components of the ECM 
due to raised fluid flux, a continuous remodelling of ECM is partly managed by 
different proteinases degrading and altering the substances of the ECM. These are 
involved in processes like wound repair and neovascularisation85.  
Beside fibroblasts, osteoblasts, and chondrocytes, endothelial, epithelial, and smooth 
muscle cells are part of the permanent connective tissue cellular network surrounded 
by the ECM. Cells outside the ECM responding to inflammatory stimuli, migrate 
from the blood into the tissue. These include leukocytes, lymphocytes, and other 
plasma cells. Either transient or stationary residence of immune competent cells, their 
inflammatory response to cellular activation precedes production and secretion of 
chemokines and cytokines86. In different animal models of pathological conditions 
accompanied by oedema, these inflammatory agents lower IF pressure together with 
local inflammation87. This demonstrates that the constituents of the ECM, and 
possibly expression of hyaluronan, are capable of actively enhancing fluid filtration88.  
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Transport of water and nutrients through the ECM depends on interstitial hydration 
and its intrinsic permeability, which is described as hydraulic conductivity78. 
Therefore, over-hydrated tissue, constituting increased permeability and area for 
transportation, will augment hydraulic conductivity, producing more rapid 
transportation of water and solutes. Conversely, dehydration and its associated 
reduced interstitial volume and compressed ECM hinders movement because of 
reduced hydraulic conductivity. Because intrinsic properties of the gel-like 
composition of the interstitial matrix hamper free flow of fluid, diffusion by kinetic 
movement allows swift carriage of electrolytes, water, nutrients of small molecular 
size and waste products between capillaries and cells. In addition, small vesicles and 
pockets of water are found within the interstitium, being able to expand immensely 
and to flow freely if tissue oedema develops7. The interstitium of skin (i.e., 
subcutaneous tissue), being the outermost body organ and readily available, has been 
thoroughly investigated in rats and mice89, 90, pigs91, 92, and human subjects93-95. They 
have a relatively high fluid content (approximately 35% of IF)52. Due to this, and the 
fact that clinical subcutaneous oedema is an early and important marker of many 
diseases, sampling of IF from the subcutis is a preferred approach. 
1.7 Regulation of body fluid volume  
A practical approach to fluid regulation is to separate the external fluid balance, 
represented by intake and output, from the internal fluid regulation between the 
different body compartments.  
The constancy of body fluids is linked to release or conservation of water in response 
to either solute or water deficit or excess. This exchange is taking place both within 
the body and with the external environment, representing a disparate milieu. Intricate 
regulation of ingested fluid and fluid synthesised from metabolic processes, together 
with loss of water from the urine, faeces, sweat, skin, lungs, and metabolic 
consumption varies both in health and disease. There are also huge inter-individual 
variations. National guidelines for adequate intake of total water differs widely96, and 
the estimated total water intake of approximately 2.3 litres/day in adults7 diverges 
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dramatically from that recorded in a recent study done in France. In that study, the 
daily total fluid intake was 1.0, 1.1, 1.3, and 1.2 litres/day for children, adolescents, 
adults, and seniors, respectively97.  
Despite huge variability in water intake, powerful mechanisms regulate and stabilise 
the extracellular volume within narrow limits, despite frequent and wide-ranging 
fluctuations in salt and water intake and losses8. The water regulatory mechanisms 
are controlled by changes in intravascular volume or plasma osmolality due to 
cellular size alterations. These are activated by fluctuations in tonicity sensors in the 
hypothalamus (plasma and in the cerebrospinal fluid), releasing a messenger hormone 
(antidiuretic hormone [ADH] or vasopressin) that communicates with the kidney to 
either excrete or reabsorb water; thirst is also stimulated98. An augmented release of 
vasopressin as a result of high plasma sodium will cause distal segments of the 
nephron to be more permeable to water. This is accomplished by an increase in the 
number of water channels, which as a result also concentrates the urine99. Similarly, 
other regulatory mechanisms maintain arterial pressure, acid-base balance, and body 
fluid osmolality through close interaction of pressure and volume receptors in the 
autonomic nervous system, endocrine systems, and central circulation99. A necessary 
loss of urine due to a required removal of solutes from the body is present under 
normal conditions, and the kidneys’ ability to concentrate urine, and therefore 
manage water homeostasis, differs according to age. Both neonates and elderly people 
have reduced ability to concentrate urine and therefore require a higher intake of a 
minimal fluid amount100. 
Balance of the internal fluid systems related to fluid movement across the capillaries 
and between the body compartments (i.e., the ECV) is driven by the equilibrium 
between oncotic pressures and hydrostatic pressures. The cell membrane separating 
the smallest compartment is permeable to water, unlike impermeant solutes (like Na+ 
and Cl-) that create an osmotic gradient between plasma, interstitial, and intracellular 
compartments. This can potentially cause huge changes in cell volume if osmotic 
equilibrium is not achieved. Therefore, the potential osmotic activity between the 
compartments can exert tremendous osmotic pressure if not corrected and, for the 
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same reason, improper fluid treatment can lead to excessive osmotic pressures. The 
osmotic equilibrium will normally not be affected by isotonic fluid in the 
intravascular space, but adding saline solution to the extracellular space without 
calculation of the tonicity of a given treatment solution, physical state, and volume of 
needed fluid, will cause fluid shifts. 
1.8 Microvascular fluid exchange and inflammation  
Acute inflammation is an early response to tissue injury. It is nonspecific, typically of 
short duration, occurs before the immune response becomes established, and is aimed 
primarily at removing the injurious foreign agent. Acute inflammation is 
characterised by exudation of fluid and emigration of leukocytes from the 
microcirculation to the area of injury; these latter cells release different inflammatory 
mediators101. These mediators may create change also in the surrounding healthy 
uninjured tissue, which is clinically characterised by rubor (redness), calor (increased 
heat), dolor (pain), tumor (swelling), and functio laesa (loss of function). These are 
known as the five cardinal signs of inflammation102. The vascular bed responds to 
inflammation, with (1) vasodilatation leading to increased local flow of blood; (2) 
increased capillary permeability, with leakage of cells, fluid, proteins, minerals, and 
salts from plasma into the interstitium; and (3) adjacent swelling of tissue due to the 
migration of cells and accumulation of fluid with concomitant inflammatory 
responses, all leading to oedema101.  
Normally, absorption of a circulatory volume increment of 0.5 litres in the IF will 
take place within 15 to 30 minutes40, whereas excessive microvascular filtration may 
lead to oedema due to alteration of the variables in the Starling equation (Eq. 1), 
changed permeability of the endothelium, or reduced drainage by the lymphatics103. 
Depending on the location of the inflamed tissue, oedema may be life threatening, 
compromising vital circulation or narrowing of the airways. This can lead to organ 
failure when local oedema-opposing mechanisms fail. It follows from Eq.1 that a 
decreased ΔCOP (reduced COPp and increased COPif ) and increased ΔP (increased 
Pc and reduced Pif), together with elevated CFC and reduced σ may greatly imbalance 
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the fluid flux (Jv). Wiig and co-workers have studied the tracheal interstitium under 
normal and inflammatory conditions, acknowledging an unexpected high COPif 
compared to COPp (85% of plasma COP) during inflammation, implying a robust 
oedema buffer ability104. This is probably due to low interstitial net fluid filtration and 
concomitant increased protein diffusion that leads to higher protein concentration in 
the IF. This is sustained during fluid overload and increased filtration (mimicking 
inflammatory conditions), because of removal of filtered fluid by the lymph.  
Oedema is a space-occupying process, and during inflammation, oedema follows 
reduction of Pif 87, although initially increased under normal conditions when 
capillary filtration is elevated8, preventing oedema formation. The rationale for a 
reduced hydrostatic IF pressure is demonstrated in vivo, with proinflammatory 
immune modulation of β1 integrins in mice dermis counteracting collagen and 
GAGs’ tensional strength and hence reducing Pif with increased fluid uptake105.  
1.9 Biochemical markers of inflammation and therapeutic 
hypothermia 
Hypoxic ischemia (HI) of nearly every organ causes initial tissue damage due to 
oxygen deficiency or reduced blood flow, and extends through the phase during 
which the organ is reperfused106. Local activation of microglia, the innate immune 
cells of the brain, induces production and synthesis of proinflammatory cytokines and 
chemokines from hypoxia-influenced tissue. An increase in white blood cell (WBC) 
production follows, amplifying the inflammatory cascade as well as further systemic 
activation of proinflammatory actions and other immune regulatory tasks107. 
Inflammation during injury is normally a beneficial physiologic response. In the 
course of reperfusion in hypoxic ischemic brain tissue, formation of reactive oxygen 
species (ROS), apoptosis, and inflammation intensifies the inflammation, stimulating 
unfavourable effects. The neuroprotective effect of TH is linked to the reduction of 
hyperaemia during reperfusion108. Expression of ROS during haemorrhagic shock is 
probably influenced by the indirect effect of temperature on microvascular 
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permeability in animal models, in which enhanced endothelial barrier function 
improves during mild hypothermia109.  
Morkos and co-workers found that elevated WBC count and actual neutrophil count 
(ANC) are related to adverse neurological outcome for non-cooled asphyxiated 
babies107, whereas Chakkarapani et al. linked low WBC count to the beneficial effects 
of TH110. Its effect on function, however, is unknown110. Complicating this finding is 
the link between severe cerebral injury and persistent low WBC when normal 
temperature is re-established111. Although studied in rats, inflammatory cytokines and 
chemokines seem to be expressed differently under hypothermic conditions, primarily 
as a consequence of reduced microglial and astrocytic activation; this reduces 
proinflammatory tumor necrosis factor-alpha (TNFα) and interleukin (IL)-6112. Down-
modulation of IL-6, IL-8, and the anti-inflammatory cytokine IL-10 during TH 
produces a better outcome113, 114, suggesting a predominantly suppressive effect on 
inflammation of these cytokines.  
1.10 Neonatal asphyxia 
Asphyxia during birth affects 1 to 10 out of 1000 live births globally115, and can be 
caused by several conditions depending on the timing of a pathologic event116. A 
newborn suffering from ante-, peri-, or postpartum hypoxia with ischemia; 
hypercapnia; and metabolic acidosis may develop hypoxic ischemic encephalopathy 
(HIE). HIE manifests in the first days of life with symptoms reflective of a 
‘disorganised’ brain, such as reduced consciousness level, seizures, decreased tone 
and reflexes, and often reduced ability to maintain adequate ventilation117. Moderate 
or severe HIE is a major source of long-term disabilities such as cerebral palsy, 
mental retardation, and epilepsy118, 119, and accounts for over 700,000 deaths 
worldwide120. 
The sustained failure of brain tissue oxygenation during hypoxia induces a switch 
from aerobic metabolism, with maintained respiratory chain activity and ATPase 
formation, to less effective anaerobic metabolism of glycolysis, with lactate 
production, causing acidosis. Unlike the adult brain, the immature brain of the 
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neonate is particularly vulnerable to this realignment of metabolic fuel use and is thus 
more susceptible to glutamate-associated neuronal damage and generation of ROS121. 
During the first phase of primary energy failure, a limited number of neurons are 
expected to die122, although the impaired cell function with cytotoxic oedema, 
accumulation of neurotoxic substances, and impaired aerobic metabolism recover 
partially during re-oxygenation123. This is followed by a latent phase of 1 to 6 hours, 
during which recovery of oxidative metabolism, residual mitochondrial injury, 
inflammation, and receptor hyperactivity occur. Due to different pathways of cellular 
mechanisms being activated or modulated, a secondary phase of energy failure, 
occurs from the first 6 to 72 hours of life124 in moderate to severe HIE. This phase is 
characterised by deteriorating mitochondrial function, accumulation of excitotoxins, 
and cytotoxic oedema. 
HIE in neonates is classified as mild, moderate, or severe, based on consciousness 
level, autonomic function, need for respiratory support, and blood acid-base balance. 
When these criteria are met, the neonate is considered for TH. Standard care and 
treatment for HIE changed dramatically in 2010, when TH was introduced to 
neonatal resuscitation guidelines125. TH consists of induction (less than 6 hours after 
birth) and maintenance of a lowered core temperature (to 33.5°C or mild 
hypothermia) for 72 hours, and is the only single treatment modality for HIE with 
proven reduced mortality and morbidity126. Although TH may improve outcome, 
many treated children still suffer from neurological disability, suggesting that 
neonates in this group are quite diverse and thus may require further stratification by 
physiologic parameters in order to determine what their optimal treatment might be. 
Treatment by whole body cooling is usually commenced in a tertiary Neonatal 
intensive care unit (NICU), although it is generally initiated in smaller units before 
transport for definitive care. Criteria for TH eligibility are shown in Table 1. By 
lowering the core temperature, all organs, and particularly the brain, are forced into a 
state of virtual ‘hibernation’, wherein metabolic demands are decreased, thus limiting 
the ongoing cellular damage127.  Other hypothermia-induced physiologic changes 
include cardiovascular and respiratory changes, which are important to acknowledge 
and need to be addressed in the context of altered physiology after perinatal asphyxia.  
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Although TH is standard care in industrialised countries and although it suppresses 
many potentially deleterious mechanisms, it is still difficult in its application to 
differentiate between cooling-induced physiological beneficial changes and changes 
that are either ineffective, or even deleterious. Also, managing primary cell death 
before initiation of cooling and subsequent rewarming is still unresolved and may 
partially explain the poor outcome for neonates with severe HIE. Hence, including 
adjunct therapy is of great importance, as it might enhance TH’s efficacy in reducing 
inflammation and cellular dysregulation. 
Inclusion criteria Exclusion Criteria 
A: Gestational age ≥ 36 weeks Expected need for surgical treatment 
(before 3 days of age)  
B: At least one of the following:  
1. Apgar score ≤ 5 at 10 minutes 
after birth                                                   
2. Requires positive pressure 
ventilation10 minutes after birth      
3. pH < 7.00 in umbilical arterial 
blood or arterial blood within 60 min 
after birth                                          
4. Base excess ≤ −16 mmol/L in 
umbilical arterial blood or arterial 
blood within 60 min after birth 
Severe birth defects with expected 
poor prognosis  
C: Signs of moderate to severe 
encephalopathy with at least one of 
the following:  
1. Hypotonia                                     
2. Abnormal reflexes or 
constricted/deviated, dilated, 
nonreactive to light pupils                
3. Weak or absent sucking reflex     
4. Presence of seizures 
Age > 6 hours before hypothermia 
could be initiated 




1.11 Hypothermia and oedema generation 
Mild hypothermia will normally decrease heart rate by 10 beats per minute for each 
1°C decrease from a starting temperature of 37°C129. This results in decreased cardiac 
output130, but less rarely, decreased blood pressure needing inotropic support126. Since 
blood pressure is the product of cardiac output and total peripheral resistance, the 
latter must increase by means of peripheral vasoconstriction to maintain acceptable 
body temperature (BT), given the small fluctuations in stroke volume that occurs 
during TH. During hypoxia, the initial vascular response is vascular dilatation, which 
serves to increase blood flow to prioritised organs, like the brain.  
The pathophysiological vascular adaptation to TH is less functionally effective in 
neonates with severe brain injury, in whom cerebral blood flow is maintained despite 
markedly reduced cardiac output accompanied by downregulated flow to other vital 
organs130. Whether this is induced by hypoxia-related alterations in local vessel 
resistance or changed perfusion pressure due to hypothermia is not known. Therefore, 
these alterations in local vascular pressure during TH would increase the possibility 
of fluid shifts occurring, leading to the development of fluid retention and 
subsequently to oedema. Also, inflammation preceding a ischemic-reperfusion injury 
is likely to trigger a cascade of local mediators that increase microcirculatory 
permeability, an effect which seems to be reduced by hypothermia in a rat model (due 
to reduced ROS production) after haemorrhagic shock109. Although most of our 
current understanding of TH and its cardiovascular effects originate from studies of 
adult humans and animal models, clinical experience and available data from 
neonates with HIE indicate that oedema formation is not appreciable131.  
1.12 A paediatric perspective 
The first line in Nelson’s Textbook of Pediatrics — one of the world's most trusted 
paediatrics textbooks — states: “Children are the world’s most important 
resource”132, implying that children are regarded as representing the future and that 
investing in their health endorses the present values of our society and the future. 
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There are clearly huge differences throughout the world in advocating the well-being 
of children, where even in developed countries, allocation of resources for this 
purpose is sometimes vague.  
Today, in the field of paediatrics, knowledge and evidence are often generated from 
data extrapolated from adults, whose medication use and dosages are based on the 
clinician’s experience and common empirical evidence. Children continuously 
mature over time, and this process is accompanied by changes in physiology and 
pathophysiology and corresponding changes in pharmacokinetics and 
pharmacodynamics. Obviously then, children need special attention and must not be 
regarded as small adults. The safety profile, efficacy, and indication for medications 
or treatment modalities for adults are different than that for children. So, using the 
adult parameters for children’s safety profiles may result in possible unintended 
harmful, or even deleterious effects in the absence of adequate research. Body fluid 
composition and therapy, for example, is one of several paediatric subfields in which 
therapeutic intervention has been much debated due to old recommendations based 
on healthy children133 and scarce evidence from a significant amount of hospitalized 
children2.  
Our present knowledge on fluid mechanics has been, to a large extent, based on 
empirical studies and extrapolation of data from animal models. The work done for 
this thesis addresses age-specific differences in some of the forces that affect fluid 
balance, variations that have not, to our knowledge, been elucidated before and thus 
may influence future liquid treatment recommendations for infants and children. In 
many senses, fluid therapy must be viewed as a drug prescription, one tailored for a 
specific need and demographic.  
These concepts and data discussed in this work are based on literature search that was 




2. Aims of present study 
The overall aim of the present study was to evaluate a simple method of sampling IF 
from subcutaneous tissue in adults under conditions aimed to reduce the procedural 
pain experience, and to determine some of the forces directing transcapillary fluid 
shift in both healthy children and sick neonates suffering from asphyxia.  
The specific aims of the study were as follows: 
1. To determine the COP and protein distribution in fluid from subcutaneous 
tissue in adults where interstitial fluid was extracted from dry and wet (soaked 
in isotonic water) nylon wicks inserted into subjects at different implantation 
times (Paper I). 
2. To evaluate whether topical application of local anaesthetics influenced COP 
measurements of IF, and to assess whether topical application of local 
anaesthetics prior to implantation of wicks lessened experienced pain (Paper 
I). 
3. To determine the relationship between COP in subcutaneous skin and plasma 
of healthy children aged 2-10 years, and to determine age-related values for 
this specific population at different implantation times (Paper II).  
4. To assess the effect of gravity on changed interstitial COP in children by 
sampling IF at increasing distances from the heart (Paper II) and to evaluate 
interstitial COP as a function of optimal implantation time of wicks in adults 
and children (Paper I and II). 
5. To determine plasma and subcutaneous COP and its relation to cytokine 
concentrations in skin and blood serum of asphyxiated neonates treated with 




3. Study populations and methods 
3.1 Study populations and study design 
Paper I 
Healthy volunteers with no chronic medical history issue and who were working at 
the Children’s Clinic, Haukeland University Hospital, were invited to participate in 
this non-blinded, sequential descriptive study. Thirty-six males and 14 females were 
enrolled. To compare equilibrium time for saline-soaked wicks and dry wicks, 20 
subjects had four dry wicks implanted in one upper arm location and four wet nylon 
wicks implanted in the contralateral upper arm. One dry and one wet wick were 
withdrawn simultaneously after 30, 60, 90, and 120 minutes of implantation; thus, 
each subject served as his/her own control subject. In 10 supplementary subjects, 
three wicks were withdrawn after 60, 75, and 90 minutes in the same manner to gain 
a better understanding of how implantation time affects COP. Twenty additional 
subjects had one wet wick implanted in each upper arm where the skin on one arm 
was preconditioned with a eutectic mixture of local anaesthetic (EMLA) cream. 
Experienced pain was assessed using a visual analogue scale. After insertion of wicks 
and achieving light venous stasis, a 5 ml venous blood sample was drawn from all 
participants.  
Paper II 
The relationship between COPif and COPp using wet wicks was investigated in paper 
II. Eighty-seven healthy paediatric patients, ranging in age from 2 to 10 years were 
included if they met criteria for tonsillectomy and/or adenotomy and/or tympanic 
paracentesis, as judged by examination of a physician at the Department of Ear, Nose, 
and Throat, Haukeland University Hospital. Twelve additional patients were recruited 
from the Department of Ear, Nose, and Throat, Akershus University Hospital, to 
boost the number of participants. Forty-five patients were females. Children were 
excluded if they had a medical history of acute illness, chronic disease, or were 
presently on medication(s) that might interfere with protein metabolism. According to 
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local policy, induction of anaesthesia and therefore implantation of wicks could not 
be performed without the subject fasting for at least 8 hours. Seventy-nine patients 
had one wick implanted in the upper arm and one wick in the medial part of the leg, 
with an implantation time of 60 minutes. An additional 20 patients, of any age 
between 2-10 years, had one wick implanted in each leg, and wicks were withdrawn 
after 60 and 90 minutes to evaluate implantation time. For all participating patients, 
when a peripheral intravenous cannula was inserted, 0.5 ml venous blood was 
collected after light haemostasis was achieved. 
Paper III 
In paper III, we evaluated capillary leakage with changes in COPif and COPp in 
asphyxiated neonates treated with TH. Twenty-nine newborns met inclusion criteria 
for neonatal TH and 17 patients were enrolled for the study at the NICU, Children’s 
Department, Haukeland University Hospital. One wick soaked in NaCl (9 mg/ml) 
was implanted in the arm or leg 6, 12, 24, 48, and 72 hours after birth. These wicks 
were withdrawn after 60 minutes of implantation time. Blood samples (0.5 ml) were 
drawn from an arterial line before implantation and withdrawal of the wick. The 
association between COPp and COPif and inflammatory processes was assessed by 
measuring a wide range of growth factors, cytokines, and chemokines, both in plasma 
and in IF during TH. 








Paper  Paper I Paper II Paper III 
Study group 
and N 
50 healthy adults 99 healthy children, 
aged 2-10 years 
17 asphyxiated 
neonates 





Wicks Total of 160 (wet 
and dry) wicks 
withdrawn at: 30, 
60, 90, 120 min; 
total of 60 (wet 
and dry) wicks 
withdrawn at 60, 
75, 90 min; 40 wet 
wicks (20 with 
local anaesthetic) 
withdrawn at 60 
min 
158 wet wicks 
withdrawn at 60 min; 
40 wet wicks 
withdrawn at 60 and 90 
min 
68 wet wicks 
implanted at 6, 12, 
24, 48, 72 hours 
after birth; 
withdrawn at 7, 
13, 25, 49, 73 
hours after birth 
Blood 
sample 
5 ml venous blood 
sample after wick 
insertion 
0.5 ml venous blood 
sample after wick 
insertion 
0.5 ml arterial 
blood sample 















mivacurium chloride.  
Sevoflurane gas 












All studies were approved by the Regional Committee for Medical and Health 
Research Ethics, Western Norway, and the Norwegian Data Inspectorate. Written 
informed consent was obtained from all participating subjects in Paper I after 
explanation of the study and responding to patient’s questions.  
The Declaration of Helsinki, which governs the ethical principles for medical 
research involving human subjects, is particularly strict when it comes to vulnerable 
groups and individuals, like the paediatric population4. The Norwegian Health 
Research Act also regulates medical and health research in Norway. It states in 
Chapter 4, paragraph 18, that consent by parents or responsible guardians for persons 
younger than 16 years who lack the ability to approve their own participation in 
clinical research must be unambiguously documented. Furthermore, the following are 
compulsory for minors participating in clinical research: (a) any risk or 
inconvenience to the person be insignificant; (b) the person himself does not oppose 
it; and (c) there is reason to assume that the results of the research can be of benefit to 
the person, or to other persons with the same age-specific disorder, disease, injury, or 
condition5. It is also a prerequisite that the research question under consideration 
cannot be reasonably answered by similar research done on adults.  
Therefore, after suitable research protocols were approved for the present thesis 
research, all patients contributing data for papers II and III were included in the 
studies only after obtaining written informed consent from either a parent or guardian 
after carefully explaining the studies to them and satisfying any questions they had. 
All three studies were done in accordance with good clinical practice and are 





3.3 Monitoring and measurements 
3.3.1 Isolation of IF 
To gain access to the interstitium, we used the wick method to isolate IF for the 
studies reported in papers I, II, and III. The method is based on the assumption that 
the time-limited, subcutaneous implantation of a wick absorbs fluid that reasonably 
represents the actual innate IF in situ. This assumption is supported by the idea that 
the content of the implanted wick, dry or preloaded with saline, equilibrates with the 
local interstitial environment and that the wick does not appreciably interfere with 
subcutaneous homeostasis. Traditionally, wicks are implanted and harvested in 
proximity to the heart, with the assumption that this location is where the average 
capillary pressure close to the level of the heart is found 134.  
The concentration of IF proteins promotes transcapillary fluid flux and can be 
measured as COPif. After Scholander described the wick method in 1968135, Aukland 
and Fadnes developed and described a modified wick method in 1973, in which 
saline-soaked wicks were introduced in the subcutis of a rat model136. The method 
was later evaluated and further developed in different animal models137, 89, 91. This 
modified method was developed, because traumatic implantation of a wick may 
‘pollute’ the IF with cellular proteins and may falsely increase capillary permeability 
with extravasation of plasma proteins, confounding true measurements of 
transcapillary fluid flux. With further refining of the method93, 138, sampling of IF 
from humans in both healthy139, 140and disease94 states by subcutaneous implantation 
of wicks is now recognised as an acceptable and representative method for sampling 
native IF, given use of optimal implantation times between 60 and 90 minutes. 
Several other techniques for isolation of subcutaneous IF are possible and are 
summarised in Table 3 (modified from Wiig and Swartz46). For human research 
purposes, wick implantation, prenodal lymphatic cannulation and suction blisters are 
of clinical relevance.  
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Method  Technique  Sampled 
material 
































Prenodal lymph Relative 
atraumatic 
Less versatile 














Non-invasive Inflammation, time 
consuming  
Table 3. Techniques for isolation of native subcutaneous IF (modified from Wiig and 
Swartz46). 
 
3.3.2 The wick method  
Double-threaded, gamma-irradiation sterilized (Institute for Energy Technology, 
Kjeller, Norway), multifilamentous nylon wicks (~0.8 mm in diameter; Polyamid no. 
8; Norsk Fletteri AS, Bergen, Norway) were used as wicks. These were introduced 
subcutaneously by straight suture needles (Acufirm, 210/3, Dreieich, Germany) in 
lengths of 4 to 5 cm. Wicks were either dry or soaked in isotonic saline. Evaporation 
of sampled IF from skin and wick was minimised by application of adhesive plastic 
film (Tegaderm, 3M, Ontario, Canada) around the injection site after implantation. 
Implantation times ranged from 30 to 120 minutes, and withdrawn wicks were placed   
into 1.5 ml Eppendorf centrifuge tubes with funnel (Sarstedt, Nümbrecht, Germany) 
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containing mineral oil. IF was separated from the mineral oil by centrifugation, and 
then the IF was aspirated and stored frozen in plastic tubes at -20°C until analysis.  
For analysis, room-tempered IF samples were transferred to non-heparinized glass 
capillary tubes by pipette and then centrifuged in a haematocrit centrifuge 
(Haematocrit 20; Hettich, Tuttlingen, Germany) to separate the mineral oil from the 
wick fluid. The effect of topical anaesthetics on the COPif measured from saline-
soaked wicks was evaluated by preconditioning of skin with 2.5 g of EMLA cream, 
covered with an occlusive dressing for 60 minutes prior to insertion of the wicks (1 g 
equals a narrow strip that is 38 mm x 5 mm wide containing 2.5% lidocaine/2.5% 
prilocaine). 
3.3.3 Analysing colloid osmotic pressure 
A colloid osmometer measures a pressure difference between a sample and a 
reference solution separated by a semipermeable membrane. If the sample contains 
large particles (e.g., particles with a molecular weight over 30 kDalton), a shift of 
water from the reference chamber to the sample chamber will create negative 
pressure, which is detected by a transducer in the reference chamber. The 
disadvantage of extracting IF from wicks is the small amount of sampled liquid 
obtained and the minimum volume needed for analysing the COP. A typical 
commercial colloid osmometer often requires a sample size of > 100 µL, and 
although the measurement volume is < 10 µL, a wick of 5 cm in length will produce 
only 5 µL of fluid. 
In 1974 Aukland and Johnsen designed an alternative colloid osmometer for small 
samples, requiring > 5 µL of fluid141. With additional technical refinement and the 
use of a low compliant industrial transducer, Wiig et al. made a reliable and accurate 
osmometer for sample volumes as little as 0.1-0.2 µL142. This type of colloid 
osmometer was used in all three papers for this thesis. The Wiig et al. device is made 
of pellucid polymethylacrylate (Plexiglas®) and acrylnitrilmethylacrylate (Plexidur 
plus) plastic (Röhm Chemische Fabrik, Darmstadt, Germany). It contains a 
transducer (SensoNor A/S, Horten, Norway) connected to an amplifier and a recorder 
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(Easy Graph P930, Gould Inc., Ohio, USA). It is separated from the sample chamber 
by a semipermeable membrane that is impermeable to molecules > 30 kDalton (PM-
30 Amicron, Lexington, MA, USA). Figure 4 schematically illustrates the details of 
this colloid osmometer. Operation of the colloid osmometer is thoroughly explained 
in paper I.  
In addition to wick fluid, serum was isolated for COP analysis. COP determined from 
either plasma or serum was reported to be equal by Noddeland93.  
 
Figure 4. Schematic drawing of the colloid osmometer used in the studies of all three 





3.3.4 Biochemical monitoring  
Patients in the studies reported in papers II and III were monitored and cared for by 
the attending physician. Additional blood tests, such as measurement of serum 
albumin and haemoglobin concentration, were analysed by an automatic colorimetric 
analyser (Cobas 8000 c702, Roche Diagnostics, USA; and CELL-DYN Sapphire, 
Abbott Diagnostics, USA, respectively) at the Laboratory of Clinical Biochemistry, 
Haukeland University Hospital.  
3.3.5 High-performance liquid chromatography by size exclusion 
chromatography 
A mixed sample of unknown contents can be analysed with high-performance liquid 
chromatography (HPLC). This method separates the sample’s constituents, quantifies 
them, and identifies them by size. The sample of interest is injected in a mobile phase 
under high-pressure through a solvent-filled column that has discriminating 
adsorption patterns for various solute components. The sorbent that divides the 
sample components is made of solid silica granulate, separating molecules by their 
size and molecular weight. Several detectors record the components as the sample 
elutes from the column. The time elapsed as the solute travels through the column 
and is eluted or detected is called the retention time. Different solutes in the sample 
will have different retention times, which provide data for analysis. Small particles 
will elute more slowly and thus have longer retention times than large particles, data 
of which can be quantified in a chromatogram. Distribution of macromolecules was 
determined in the IF obtained from the wick method and in plasma by high-resolution 
size exclusion chromatography in paper I. Size distribution of proteins from IF 
(obtained from dry and wet wicks) and plasma were compared to determine whether 
implantation of wicks caused enough bleeding to sufficiently contaminate IF.  
3.3.6 Determination of inflammatory markers in IF and serum 
In paper III, a multiplex, magnetic bead immunoassay (Milliplex HCYTOMAG-60K; 
Merck Millipore, Damstadt, Germany) was used to determine and simultaneously 
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analyse the levels of 15 different cytokines present in IF and in serum. All procedures 
were performed using the manufacturer’s recommendations. IF and serum were 
analysed at a 1:12.5 dilution using a Luminex 100™ (Luminex Corp.) instrument 
with StarStation software (Applied Cytometry Systems, Dinnington, UK); samples 
were analysed at the Broegelmann Research Laboratory, Department of Clinical 
Sciences, University of Bergen. Arterial blood was allowed to clot for approximately 
30 minutes, and then was centrifuged to separate serum; serum was aspirated and 
then stored in plastic tubes at -20°C until analysis.  
For analysis, samples were subject to two freeze-thaw cycles. The following 15 
cytokines were assessed: interferon gamma (IFN-γ), interleukin-1α (IL-1α), 
interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1RA), interleukin-2 (IL-
2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-
12p40 (IL-12p40), monocyte chemoattractant protein-1 (MCP-1), macrophage 
inflammatory protein-1α (MIP-1α), transforming growth factor-α (TGF-α), tumour 
necrosis factor-α (TNF-α), tumour necrosis factor-β (TNF-β), and vascular 
endothelial growth factor (VEGF). All values were reported as picograms per ml 
(pg/ml). Results were not verified by parallel tests due to small amounts of source 
material. 
3.3.7 Neonatal TH and ventilation 
Patients in the study reported in paper III were all admitted to our NICU and were 
treated with TH to temper or completely prevent the deleterious effects of neonatal 
asphyxia. Lowering the core temperature of an organism decreases metabolism, and 
all body functions are virtually in a neuroprotective state of hibernation.  
According to protocol, the patient was placed in an open incubator (Dräger 
Babytherm 8010, Dräger Medical, Lübeck, Germany), and TH induction (decreased 
body temperature and maintenance of mild hypothermia at 33.5°C) was managed by 
servo-controlled, whole-body cooling equipment (Criticool, Mtre, Pennsylvania, 
USA). All babies born from January 2011 onward were ventilated during TH with a 
Dräger Babylog® VN500 (Dräger Medical, Lübeck, Germany), and before 2011, 
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they were ventilated with a Stephanie Neonatal and Paediatric ventilator, (Stephan, 
Gackenback, Germany). Neonates were maintained hypothermic for 72 hours after 
birth, and then they were gradually rewarmed to 37°C, a process that took 
approximately 12 hours.  
3.3.8 Cerebral monitoring 
Brain function was assessed during TH by monitoring the child’s 
electroencephalogram (EEG) and amplitude-integrated electroencephalogram 
(aEEG), (both Viasys HealthCare, NicoletOne, www.carefusion.com). This is a 
relatively non-invasive way to monitor brain function over time, recording voltage 
gradients originating from the brain tissue using needle electrodes on the scalp. Both 
short-term and long-term EEG monitoring provide information on possible brain 
dysfunction143, and is a valuable tool together with magnetic resonance imaging 
(MRI). MRI was performed on patients with the expected poorest prognosis during 
cooling (second or third day of TH). Otherwise, patients underwent cerebral 











SigmaPlot 11 (SyStat Software, Inc., Germany) was used for statistical analyses. 
Two-tailed paired t-tests were used for comparison of different groups in paper I and 
all values were presented as means ± one standard deviation (SD).  A P value < 0.05 
was considered significant in all papers 
Results in paper II are presented as numbers with proportions (% of total) and means 
and plus/minus one SD. One-way ANOVA was used for evaluating the COPp and 
COPif for the different age groups, followed by an all-pairwise Holm-Sidak multiple 
comparison procedure, if a factor was significant in the one-way ANOVA. When 
comparing smaller groups with non-normally distributed data, we used a non-
parametric test (Mann-Whitney).  
In paper III, one-way ANOVA was used to evaluate COPp, COPif, cytokines, MAP, 
and fluid balance across different treatment time points. If there was a significant 
difference between the groups, an all-pairwise multiple comparison procedure (Holm-
Sidak) was used to assess reliable differences in specific groups. Nonparametric tests 
for correlation calculations of continuous variables were performed by Spearman’s 
rank correlation test, and categorical variables were analysed by the Mann-Whitney U 
test. Continuous variables were expressed as means ± SD, and categorical variables 







4. Summary of results 
Paper I: Effect of topical anaesthetics on interstitial colloid osmotic pressure in 
human subcutaneous tissue sampled by wick technique. 
Background: The Starling equation describes the different forces that determine fluid 
flux over the microvascular wall, where the transcapillary difference in COP is 
important for capillary exchange of water. Measurement of COP in IF can be done by 
subcutaneous implantation of nylon wicks. However, wick implantation time and the 
use of dry versus wet wicks remain controversial issues. Additionally, the use of 
topical anaesthetics in this context may reduce the experienced pain from 
implantation of the wicks, but it may also alter microcirculation in the skin, indirectly 
confounding true COP values.  
Methods: COP was measured in plasma and IF from skin of healthy adults using dry 
or wet wicks. Wick implantation times ranged from 30 to 120 minutes, and the skin 
was partial pretreated with topical anaesthetics (EMLA cream®).  
Results/Conclusions: The use of topical anaesthetics did not influence interstitial 
COP values, and this modified procedure was subjectively experienced as being less 
painful. The water content of wicks before implantation also did not affect interstitial 
COP when using implantation times between 60 and 90 minutes. The COP data 
obtained in the present study were similar to reference data obtained using other 
sampling methods. Moreover, our COP results indicate that a wick implantation time 
between 75-90 minutes is optimal.  
Paper II: Interstitial colloid osmotic pressure in healthy children. 
Background: Normal and specific pathological values of both hydrostatic pressure 
and COP measured in plasma and interstitial fluids are known for adults and to some 
extent in newborns. However, an information gap still remains for the paediatric 
population in understanding microvascular permeability. The link between interstitial 
and plasma COP as a function of age and implantation time for children is unknown. 
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Moreover, whether gravity influences COP at distances peripheral to central 
circulation remains a question. 
Methods: IF was harvested at different time points below and at the heart level in 99 
presumably healthy children between 2 and 10 years old. The children were sedated 
and intubated during a minor surgical procedure.  
Results/Conclusions: Plasma COP values for children were similar to those of adults. 
Increased plasma COP and interstitial COP with advancing age resulted in a raised 
transcapillary gradient for COP. Neither implantation time for 60 or 90 minutes nor 
harvesting of IF close or distant to the heart affected COP. 
Paper III: Transcapillary fluid flux and inflammatory response during neonatal 
therapeutic hypothermia (submitted). 
Background: Perinatal asphyxia leads to hypoxic ischemic encephalopathy. 
Treatment with TH may be neuroprotective by reducing metabolism and supressing 
the immune system. The physiological response to hypothermia and its effect on 
epithelial permeability is unclear. Moreover, few studies have addressed the 
mechanisms of fluid imbalance during TH, which can lead to fluid overload and 
oedema formation. If interstitial and plasma COP change during hypothermia, could a 
local inflammatory response be detected at the tissue level?  
Methods: IF was harvested from nylon wicks at different times after implantation, 
and COP was measured in plasma and the interstitium, together with measurement of 
selected markers of inflammation.  
Results/Conclusions: Asphyxiated neonates had reduced COP both in plasma and the 
interstitium, creating an unaltered COP gradient opposing fluid extravasation. No 
visible oedema was experienced in subjects. IL-1α in the interstitium was elevated 
during TH, and was modestly correlated with decreased mean arterial pressure. This 




5.1 General discussion; methodological considerations  
Understanding the mechanisms governing fluid flux across capillaries in children is 
based mostly on knowledge and experience gained from adults. One issue that still is 
a matter of debate is haemodynamic control using fluid-therapy management 144, 145. 
When fluid leaves the capillaries and distributes throughout the interstitium, 
interacting with the local environment, the balance of forces regulate the amount of 
fluid remaining in the interstitium. Elevated fluid accumulation in the tissue and 
oedema may be the result of enhanced endothelial permeability, imbalance between 
the colloid osmotic and hydrostatic forces, or to reduced lymph drainage40. To 
understand these processes from a paediatric viewpoint, one must first understand the 
normal states in this population. The limited ability to include children in clinical 
research has, until recently, restricted our knowledge to a certain extent.  
This thesis work focused on gaining a better understanding of fluid shifts between the 
capillaries and the interstitial space in adults, children, and neonates under both 
normal physiological conditions and severe asphyxia. Attention was especially 
focused on the methodology used to sample IF in humans and gaining new 
knowledge of interstitial inflammatory mechanisms that contribute to altered water 
balance under hypoxic circumstances. These could potentially favour fluid shift from 
the circulation to the interstitial compartment. 
5.1.1 Reliability of the wick method 
To accurately determine COP of the IF (i.e., the plasma proteins and ultrafiltrate of 
plasma, and possible bioactive compounds in IF), the following assumptions about 
the fluid sample must be true: (1) the sample represents native IF in undisturbed 
tissue, and (2) the sample represents the ‘true COP’ acting outside of the capillary 
wall.  
Therefore, the methodology of isolating IF from vascularised subcutaneous tissue has 
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been developed and refined over the last 40 years, and different techniques have been 
compared to assess the validity of different sampling methods8. The introduction of a 
device through the skin will certainly disrupt to a degree the natural in situ state of the 
interstitium; this is unavoidable. However, the practical questions are whether it 
samples the interstitium in a sufficiently natural state, and whether the method is 
applicable with only minor discomfort for the patient. Experience and studies suggest 
that the wick technique is the most appropriate for studies of human IF. The different 
methods for native IF isolation are summarised in Table 3. The functional mechanism 
of and issues using the wick technique will now be discussed.  
Implantation of a wick in the IF for a specific period of time, equilibration with the 
interstitial surroundings, and subsequent removal of the wick, are prerequisites for 
analysing the wick content. It is obvious that the wick volume must equilibrate with 
the relatively greater volume of interstitium and preferably without any disrupting 
influence on measuring the true COPif. When introduced by a needle into the IF, 
however, the relatively large volume of the wick, compared to that of the capillaries, 
causes some tissue trauma and local inflammatory reaction146. Inflammation may 
alter local endothelial permeability to some degree, intensifying the already on-going 
leakage of both plasma proteins and blood cells. This reaction is evident by increased 
uptake (in wicks) of labelled albumin from the blood after 30 minutes of 
implantation93, and by a comparable albumin/globulin ratio in prenodal lymph after 
additional implantation time146. However, native IF, free from inflammatory and 
dilutional influence, can be obtained in a rat model. In the model, anaesthetised rats 
are killed before implantation of wicks, and therefore native IF can be examined in 
the absence of circulation. Kramer et al. found only 1-3% of labelled albumin in 
wicks from such an experiment, indicating short-term implanted wicks have an 
insignificant influence on interstitial protein137.  
In an experimental rat model, it was shown that endothelial ‘leak’ was reduced by 
Non-steroidal anti-inflammatory drugs (NSAIDs), followed by a reduced wick COP 
and interstitial hydrostatic pressure146. This indicates that some protein leakage is 
required to compensate for the dilutional effect of wick implantation on the IF, and 
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hence the interstitial protein content. In paper III, we showed that throughout TH, the 
proinflammatory cytokine IL-6 was expressed at lower levels in IF compared to 
serum. This result supports the notion of negligible and transitory tissue damage and 
subsequent inflammation occurring when using the wick technique. Also, a saline-
soaked wick may initially dilute the IF, and therefore the interstitial protein content. 
Then, because of a low attained protein content of the wick, a negative hydrostatic 
pressure follows. Because of its resistance to dehydration, an underestimate of COPif 
occurs as a consequence146. A small influence of protein concentration is evident 
when comparing wick-fluid-to-protein ratio of dead and anaesthetised rats137, and this 
is in agreement with the assumption of reduced inflammation and osmotic 
equilibrium after 60 minutes of implantation146. 
To achieve a measurement of ‘true’ IF, under conditions in which there is equilibrium 
between wick, plasma proteins, and IF and with suppressed inflammation, the 
‘crossover technique’ can be employed89, 91. With this method, saline-soaked wicks or 
wicks soaked with systematically varying concentrations of protein are implanted in 
rats shortly after circulatory arrest. Different time points are used, and COP of the 
priming solution and COP from wick fluid is recorded and plotted in a linear fashion. 
The protein concentration that remains unchanged throughout implantation represents 
the ‘true’ COPif. Kramer137, Wiig89, and Heltne91 all found a higher COPif when using 
the crossover method and one-hour implantation times compared to COPif obtained 
with the saline-soaked wicks. This outcome was probably due to known issue that 
wet wicks tend to dilute IF ex vivo, with an expected lower COPif. Additionally, 
Kramer found a significant change in protein content but not COPif, suggesting that 
the wick fluid represents osmotic equilibrium but not necessarily protein 
compositional equilibrium. Unfortunately, human in vivo experiments using the 
crossover technique are, at best, very difficult to conduct. 
Because of the lack of a true ‘gold standard’ or reference method for IF sampling, 
exploration of other possible methods have led to an even better understanding of 
COPif. In anaesthetised rabbits (both control settings and volume expansion), COP in 
sampled prenodal lymph and wick fluid are correlated147. Calculated COP in 
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matching fluid from implanted capsules are also correlated148. The suction blister 
technique, is a third way to harvest IF, although with it, hyperfiltration of fluid and 
lowered protein content are known to occur46, which lead to a slightly under 
estimated COPif of approximately 25% compared to the wick method. However, it is 
in good methodological agreement with the wick technique138. A rather new method 
to isolate native IF is tissue centrifugation, in which excised tissue is exposed to 
centrifugal G-force, leading to precipitation of IF149, 150. Brekke et al. compared tissue 
centrifugation to wicks in a swine model with increased fluid load, and found that the 
wick technique underestimates COPif151. It should be understood, however, that in 
this head-to-head comparison, it is not unreasonable to expect a higher COPif with 
centrifugation due to additional cell debris and proteins present in this method. 
Interestingly, the measured COPif from wet wicks was close to that measured 
previously using crossover techniques91 and similar wet wick experiments152, 153. The 
centrifugation method is not suitable for human in vivo studies, although use of this 
method in isolation and proteomic studies of tumour IF may be important for 
detection and monitoring oncological disease154.  
For the purpose of human experiments, the wick method is likely the most convenient 
and clinically applicable approach, since it is less traumatic and produces less 
inflammation when allowing for sufficient time for the wick to equilibrate.  
5.1.2 Wick results are not affected by haemoglobin contamination 
It is essential for the wick method that the extracted liquid be comparable to the 
native IF of the relatively undisturbed subcutaneous environment. It is understood, 
however, that the introduction of a wick via surgical needle may cause some trauma 
with different grades of bleeding and associated leakage of products from the 
bloodstream. Aukland and Fadnes demonstrated that an admixture of blood or 
erythrocytes might lead to a markedly elevated COPif, if this represents more than 5% 
of the total protein concentration. Their studies recommend rejection of withdrawn 
wicks that are clearly smeared with blood, as these contain more haemoglobin than 
0.2 g/dl136. However, in a related study, Noddeland compared duplicate samples of 
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pink and clear wick fluids and showed that these had similar COPif values, providing 
evidence that measurement of COPif from withdrawn wicks that are pink-coloured 
can be valid134.  
A low fraction of haemoglobin was confirmed in Paper I where we performed HPLC 
on wet and dry wicks of visual clear and light pink character140. We found virtually 
identical protein peaks in plasma and IF, as well as traces of haemoglobin in the 
latter, all in line with similar findings in animal models using the wick technique151, 
indicating minimal admixture of haemoglobin or protein contaminants. An increased 
representation of haemoglobin or protein would lead to an overestimate of COPif. 
Previous human studies using wicks have reported that bleeding is a minor problem, 
with 7-15% of wicks having to be discarded because of protein contamination93, 155, 
156. For wick implantation in these experiments, all subjects received intradermal 
injections of local anaesthetic lacking adrenaline (vasoconstrictor). In our 
experiments, we observed more frequent blood contamination of wicks, reaching 
22% of wicks in paper I, 19% in paper II, and 32% in paper III. One probable 
explanation may be that when the interstitium lacks the small liquid volume 
introduced by the anaesthetic injection, less bleeding occurs, since there is no mass 
effect on local haemostasis. This possibility is in line with Rein et al., who used no 
local anaesthetic for wick implantation and recorded a bleeding frequency of 20%157. 
Comparing the activity of patients contributing data for papers I and II, those in paper 
I commenced daily activity after wick implantation, likely having limb movements 
that could induce microscopic bleeding near the wick. Evidence from other domains 
speaks to this issue. For example, patients suffering from hypothermia have inhibited 
coagulation enzymatic reactions127, 158, and neonates that bleed during TH treatment 
are reported to show lowered platelet counts at the beginning of TH159. This is all in 
line with the rather increased proportion of blood-stained wicks we observed in the 
studies reported in paper III. We were concerned by this but were also constrained in 
our attempts to increase the number of observations when the implantation of wick 
produced bleeding. Due to our approved protocol and to the physically limited area 
for wick implantation in neonates, we saw no option for inserting additional wicks.  
 59 
5.1.3 Acceptable wick implantation time ranges between 60 to 90 minutes 
Another, and maybe more important, inherent problem with in vivo implantation is 
the inflammatory reaction that results from tissue being traumatized, which leads to 
the above-mentioned extravasation of plasma proteins and fluid. Earlier work with 
sampling IF in animals has revealed differences in this outcome in relation to type of 
tissue and species studies89, 136. Noddeland was first to systematically study 
implantation times ranging between 30 and 180 minutes and their effects on osmotic 
equilibrium in human subjects93. The time-dependent equilibrium for water and 
protein associated with less severe inflammation for COPif measurement is close to 
60 minutes. This is due to the fact that 80% of labelled albumin was wick-bound at 
30 minutes, resulting in COPif increasing slowly after 60 to 120 minutes93. This result 
agrees with the COPif measured from both wet and dry wicks used in paper I.  
The initially high COPif measured from dry wicks and then decreasing COPif 
measured from 30 to 60 minutes later (paper I) probably reflects leakage of plasma 
proteins into the wick, which subsequently decrease as implantation proceeds. This is 
a tendency that was also observed with wet wicks, and is in agreement with previous 
observations146. Kramer et al. reached the same conclusion, in which inflammation 
marginally influenced protein concentration in the wick after one hour of 
implantation137. In a related study, Wiig et al. found the ‘true’ COPif using the 
crossover technique, showing that it slightly increases compared to COPif measured 
in wet wicks after 60 and 90 minutes of implantation. His studies sampled IF from rat 
tissue that had functioning circulation, and they reported that the dry wick fluid was 
closer to the ‘true’ COPif89. If the same situation is applicable in humans, the 
observation we reported in paper I that a slow but statistically non-significant 
increase in COPif occurs for all wicks between 75 and 120 minutes after implantation, 
can be ascribed to local inflammation related to mechanical tissue trauma. Assuming 
that the inflammation due to wick implantation is transitory and that an osmotic 
equilibrium in the normal interstitium is achieved in approximately 60 minutes89, 137, 
it is reasonable to accept 60 to 90 minutes as the preferred implantation time. Sixty 
minutes was selected as the standard implantation time in all the present thesis 
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experiments, although absolute conclusions about optimal implantation time are still 
not firmly established and need further study.  
5.1.4 Local anaesthetics, microcirculatory changes and visual pain score 
When harvesting IF from dry wicks, small volumes of fluid are obtained, which 
precludes multiple analyses137. The saline in wet wicks act as a medium for diffusion, 
and these wicks demonstrate from our pilot studies to cause less pain during 
implantation. Implanted dry wicks measure a significantly higher COPif after 60 and 
90 minutes in rats89. Saline-soaked wicks are primarily used in human studies 160, 161, 
162, 163, 164, 138, 165, 94, 68, 166, as was used in the studies reported in papers I, II, and III. 
Less fluid was extracted from wet wicks in neonates (paper III) than in children 
(paper II) and less than in adults (paper I) due to the length of the implanted wick. 
However, the procedure still harvested enough IF for COP measurements and some 
additional tests.  
The vasoconstrictive properties of topical skin anaesthetics (EMLA) primarily affect 
small vessels167, is time-limited, producing delayed vasodilatation168, and is rapidly 
reversed after wick removal from the skin. The finding of a non-significant difference 
in COPif measured from wet wicks with and without EMLA application with 
increasing implantation time indicates that minor changes in local microcirculation 
occurred (paper I). Interestingly, the lower COPif measured from skin treated with 
EMLA increased gradually, corresponded with COPif measured at 90 minutes from 
skin lacking EMLA application, and peaked at 120 minutes of implantation. One 
explanation may be that pre- to post-capillary resistance ratio is reduced, with slightly 
raised filtration pressure and reduced protein concentration. One can speculate 
whether the vasoconstrictive effect, known to diminish over time, restores filtration 
before increased vasodilatation and possibly local inflammation takes over, and hence 
protein leakage into the IF.  
Pain assessment during introduction of the needle for wick implantation and suturing 
with nylon thread showed that pain, as measured on a visual analogue scale (VAS), 
was significantly lower, which is consistent with the dermal and intramuscular 
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analgesic effect of local anaesthetics169. Lessening of experienced pain and the minor 
effect on COPif, may contribute to the efficacy of the wick method in subjects who 
dislike medical procedures, especially those involving needles. This may be 
particularly important when studying children in future studies. 
5.1.5 General anaesthetics’ influence on the microvasculature 
General anaesthesia and short-term sedation with propofol (2,6-diisopropylphenol) 
and sodium thiopental are commonly used in humans as intravenous anaesthetic 
agents to facilitate smooth transition to unconsciousness. Both agents are known to 
produce a dose response decrease on blood pressure, and propofol is known to lower 
vascular resistance accompanied by a diminished baroreceptor reflex and reflex 
tachycardia170. De Blasi and co-workers, for example, observed a propofol-induced 
increased muscle blood flow and decreased resistance in muscle microcirculation 
compared to sevoflurane171, which facilitated a possible fluid shift to the interstitium. 
In a related study, Bruegger et al. measured CFC in the lower limbs with a non-
invasive, computer-assisted venous plethysmograph and found that sevoflurane 
decreases CFC with less perioperative fluid substitution in contrast to propofol in 
women undergoing breast surgery172. By contrast in a pig model, propofol 
administered during cardiopulmonary bypass decreased fluid extravasation by almost 
30% compared to isoflurane, and the pigs receiving propofol had significantly higher 
COPif and less tissue oedema92. These findings are relevant to the results discussed in 
this thesis. 
Patients in the studies reported in paper II primarily received propofol during 
anaesthesia maintenance during surgery (some were sedated with the volatile gas 
sevoflurane), and although nearly 80% of patients received more than their basic fluid 
requirement, no clinical oedema was observed. Also, the mean COPif for all 
participants was 13.9±3.5 mmHg, which is comparable to normal adult values. It is 
reasonable to believe, then, that the use of propofol in surgical anaesthesia 
maintenance is associated with negligible fluid extravasation. 
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5.1.6 Analysing COP in serum 
A marked fall in plasma COP observed after wick implantation in rats can be 
explained by the magnitude of insertion trauma and time after implantation for 
plasma sampling89, 173. Although decreased COPp due to trauma is less likely in 
humans because of their greater skin-to-surface ratio, the plasma COP should 
optimally be sampled at the same time as harvesting the wicks. Optimally, it should 
not be done before implantation, because the blood loss potentially could alter COP. 
Although measuring a normal COPp before wick implantation in patients with blood 
loss over 10% of circulating blood volume (CBV) (paper II), we observed that the 
mean COPif in this group was significantly higher than the COPif obtained from the 
other patients (16.0 ± 4.0 mmHg vs.14.0 ± 3.6 mmHg, P = 0.048, arm and leg values 
averaged). This is in agreement with increased sympathetic-mediated pre-capillary 
resistance causing a larger increase in COPp compared to Pc accompanied by a 
corresponding fluid absorption to maintain circulatory balance. In patients who had 
no obvious bleeding in the studies of paper III, we measured plasma COP in 12 of 17 
patients during wick insertion and immediately after withdrawing the wick. This 
comparison revealed practically the same COPp values throughout TH.  
5.2 Specific discussion 
Wiig and Noddeland have thoroughly evaluated the working mechanism of implanted 
wicks in rat models and recommended implantation times between 90 and 120 
minutes (dry and wet wicks)89; they recommend an implantation time of 60 minutes 
(wet wicks) in humans93. Results using dry wicks used in paper I support this view 
and the finding of an unchanged COPif measured at 60 and 90 minutes. This is 
apparently inconsistent with findings from previous studies but can be understood by 
a consideration of technical issues. Increases in COPif measured using both dry and 
wet wicks between 75 and 90 minutes after implantation93 can be explained by local 
inflammation related to mechanical tissue trauma. An implantation time of 120 
minutes seems to represent a plateau phase, producing practically equivalent COP 
values measured from dry and wet wicks.  
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To our knowledge, COPif measured between 60 and 90 minutes has not been done 
before in humans, confirming our COPif findings at 75 minutes. A small, non-
significant increase in COPif measured from the leg was observed between 60 and 90 
minutes (11.3±2.8 mmHg to 12.9±3.1 mmHg) in the studies reported in paper II. This 
also indicated a lessening effect of interstitial saline diluting and transient local 
inflammation. We assumed that since the subjects participating in the studies of paper 
I were all healthy volunteers, the reflection coefficients and capillary filtration 
coefficients remained normal and unchanged, leaving only ΔP and ΔCOP as potential 
variables in the Starling equation (Eq. 1). Therefore, based upon previous experience 
and our own results, 60 minutes was confirmed as standard implantation time.  
5.2.1 COPif in adults and children 
In humans, COPif measured with wet wicks in normally hydrated subcutaneous tissue 
of the thorax region is reported to be in the range of 12.5-21 mmHg (mean ~16 
mmHg at 60 minutes of implantation)68, 134, 174. This differs somewhat from our 
results reported in paper I. There, we reported a higher mean COPif of 20.5±4.5 
mmHg (range 14.8-29.9 mmHg) after 60 minutes of implantation. This difference 
may be due to higher wick protein content or to slight methodological differences. A 
higher mean COPif was not associated with an elevated mean COPp, which for 
subjects in the studies of paper I, was 27.6±1.8 mmHg (range 23.8-31.8). This would 
have decreased ΔCOP, favouring increased filtration from the capillaries and 
filtration by lymph, avoiding excessive interstitial fluid accumulation.  
The experiments done for this thesis were done according to protocol and followed 
the methodological details of previous studies. Our previous pilot and similar studies 
from our group have produced comparable results to those reported by Bates68 and 
Noddeland93. Although methodological errors or slight differences in our studies 
seem less likely, it should be noted that Noddeland injected local anaesthetics before 
implanting all wicks, potentially diluting the IF and lowering the measured COPif. 
The dilution of local protein concentration introduced by the injection volume is still 
less likely, since Bates used EMLA cream as a local anaesthetic, yet he reported a 
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similar COPif68. Also, the protein content in IF from wicks produced a similar protein 
peak and elution pattern as that obtained from plasma samples. One exception is a 
small peak in the low molecular weight range that is probably the peak for 
haemoglobin, indicating no interstitial proteins brought about a higher COPif.  
Noddeland observed an elevated COPif measured in the morning and a lowered COPp 
measured in the afternoon93. He also reported that COPif sampled from the thorax 
showed non-significant body-posture–dependent variations134. All of our subjects in 
the studies of paper I were examined in the morning, and assuming both arm and 
thorax represent proximity to the heart, the higher observed mean interstitial COP 
probably reflects variation of normal physiology. The fluctuations of COPp seen in all 
three papers are in accordance with other authors’ results, and most likely reflect 
individual differences within a given study population. This is underscored by the 
findings of moderately low COPp relating to low COPif, the association being more 
pronounced after 90 and 120 minutes of implantation.  
Due to a lack of previously unknown COPif values in children, the age span of 
subjects should ideally include infants and children, from teenagers to adolescence. 
Our protocol used for the studies reported in paper II aimed to assess presumably 
healthy children, so did not involve patients covering this entire age range. This is 
because infants and older children are not admitted to the outpatient clinic. Moreover, 
the wick method is not pain-free, and the use of local anaesthetics does not entirely 
remove the presumed sensation of discomfort, precluding its use — for ethical 









5.2.2 Effect of gravity and age on COPif 
 
Since the venous hydrostatic pressure increases with increasing caudal distance from 
the heart in an upright position (and therefore increased Pc), an expected change in 
Pif, COPif, or COPp from Eq.1 will prevent excessive fluid filtration in the lower 
extremities. Measuring the arterial, capillary, and venous hydrostatic pressure (i.e., 
Pa, Pc, and Pv) in the foot of a standing subject, Levick and Michel found increments 
of Pa and Pv to be higher than the corresponding increments in Pc due to the high ratio 
of pre-to-post-capillary resistance modulating Pc close to Pv50. In a study exploring 
body-posture–dependent fluctuations, Noddeland demonstrated a significant increase 
in calculated Pc measured in the ankle compared to that measured in the thorax, and a 
reduction in COPp. There with only minor changes in both COPif and Pif measured 
from an upright or horizontal position, but more importantly, Noddeland observed a 
significantly reduced COPif measured in the ankle compared to that measured in the 
thorax134. These findings are somewhat at variance with ours. 
In the studies reported in paper II, we found no significant difference in COPif 
measured from the arm or leg. COPif measured in the arm was just above COPif 
measured in the leg of patients from 2-7 years of age (mean COPif 14.2± 3.5 mmHg 
in ankle vs. 14.3± 3.4 mmHg in arm); there was an increased difference in patients 8-
10 years of age. Subjects in the studies of paper II were positioned in the horizontal 
position for at least 1-2 hours before sampling of IF, which is 1 or 2 hours less than 
that in the Noddeland study. Prolonged horizontal positioning of patients in this latter 
study may have produced a greater difference. By contrast, our findings suggest that 
children do not experience the same orthostatic effects on COPif as adults, a notion 
underscored by the lower COPif measured in the leg than in the arm for patients 
closest in age to adulthood. This was not the case, however, for the younger children 
in the study. It remains uncertain whether there is a larger orthostatic effect with 
respect to height and poorer venous drainage correlated with age-specific 
characteristic changes in the veins or with less physical activity.  
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5.2.3 Adults and children have similar COPp  
 
The reported normal mean adult plasma COP of 25 to 27 mmHg93, 95 is close to the 
mean COPp of 27.6±1.8 mmHg for adults reported in paper I. These adult values are 
also close to the mean COPp of 25.6 ± 3.3 mmHg we measured in children reported in 
paper II. The significant increase we observed in COPp from 24.6 ± 3.2 mmHg at 2-3 
years to 28 ± 4.2 mmHg at 8-10 years of age (P = 0.02) in paper II is also in 
continuum with the results from Sussmane et al. They reported that COPp increased 
with age in the first postnatal year (mean 25.1±2.6 mm Hg59). The age-dependent 
increases in COPp up to 12 months of age may be attributable to the coinciding 
reduction in TBW and extracellular fluid (see Figure 1), together with increased 
serum albumin during infancy175. An increased serum concentration of proteins (other 
than albumin) with advancing age175 supports the corresponding observed elevation 
of both COPp and COPif in paper II. 
 
The rise in ΔCOP from 2-7 years of age favours transport of fluid into the capillaries 
and accompanying reduced absorption of fluid by the lymphatic system in order to 
preserve homeostasis. Whether this is an oedema-preventing mechanism related to 
patients being immobilised and thus having less effective lymphatic drainage is 
unknown. On the other hand, ΔCOP decreasing in the 8-10-year-old group is 
probably a result of higher COPif compared to a net increase in COPp that occurs with 
age. If this is caused by a hydrostatic effect of patients being taller or by a result of 
too few observations in our study remains uncertain. 
5.2.4 COP in the asphyxiated neonate  
 
Several authors have analysed plasma COP in term- and pre-term neonates, reporting 
decreased COP with increasing gestational age (19.5 ± 2.2 mmHg for term62 and 15.4 
± 1.3 mmHg for preterm babies63). Neonates with respiratory distress, regardless of 
maturity, have a further reduced COP176. COPp also correlates with birth weight and 
gestational age in healthy neonates, in which term babies delivered by caesarean 
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section have equal to or reduced plasma COP compared with those born vaginally177, 
178. Neonates suffering from asphyxia in the studies of paper III had the highest 
average value of COPp (15.7±1.9 mmHg) 6 hours after birth, slowly decreasing with 
time and with no significant change during TH; this is in line with the above-
mentioned studies. Also, these studies confirmed a reported correlation between COP 
and total plasma protein, which also is consistent with our findings of albumin 
concentration (represents approximately 80% of COP) within the reference range 
during TH. Ekblad and co-workers observed a higher plasma COP in neonates 
suffering from asphyxia compared to that of healthy babies179, which is opposite to 
the finding of Wu et al.180, possibly due to the fact that study groups were dissimilar.  
The effect of global ischemia on reduced COPp in neonates still remains uncertain. 
The lower but rather constant value of COPp, along with a reduced haematocrit, 
partly reflects dilution of plasma proteins after resuscitation and associated 
intravenously administered fluid, followed stabilisation with fluid restriction (paper 
III). This is consistent with the initial increased fluid surplus compared to rest of the 
TH period. The persistent fluid excess may be partly due to hypothermic skin 
vasoconstriction, reduced urine output, and mechanical ventilation. Counteracting 
this, global ischemia with shedding of the endothelial glycocalyx, loss of barrier 
function, and increased vascular permeability (demonstrated during vascular surgery 
and global ischemia in humans181) will potentially promote a fluid shift towards the 
interstitium, concentrating plasma proteins and reducing COPif. The latter view is 
supported by the finding reported in paper III of a nearly halved COPif (9 mmHg) 
compared to infants and children (14 mmHg) throughout TH. The relatively unaltered 
COP gradient and decreased serum albumin raises several questions. Do other 
compensating plasma proteins maintain COPp during TH? Or, are equal amounts of 
fluid and protein transported across the capillary to the interstitium? The latter is most 
likely, since ischemia triggers inflammation, which will additionally increase 
hydraulic conductance permeability to proteins and a decrease in the protein 
reflection coefficient. Additionally, the finding of decreased axillary microcirculatory 
blood flow (lowered MFI) during TH in asphyxiated neonates32 can be interpreted as 
reduced microvascular pressure, reducing the ongoing leakage.  
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5.2.5 Asphyxia and markers of inflammation 
 
Deep hypothermia and cardiopulmonary bypass (CPB) are known to elicit fluid 
extravasation, probably caused by liberation of inflammatory mediators182, 183. The 
finding of minimal loss of proteins in the interstitium with these procedures raises 
questions about whether CPB or hypothermia is the true cause of fluid extravasation. 
For example, surface cooling to 28°C in piglets results in a parallel shift of fluid and 
protein into the interstitium, suggesting that temperature-related induction of 
inflammation changes endothelial permeability, similar to what is observed in 
ischemia reperfusion injuries152. Heradstveit and co-workers observed that when both 
hypothermia and asphyxia are present in post-cardiac arrest survivors, treatment with 
mild hypothermia (TH) to a core temperature of 33°C results in a similar decreased 
plasma and interstitial COP94, a finding consistent with our results reported in paper 
III. However, one difference is that these patients were administered fluids and 
vasoactive medication in contrast to the piglets94. This leads to a search for other 
possible mediators. 
Experimental models of mild hypothermia imply that capillary perfusion is preserved 
and ischemia-triggered leucocyte-vessel activation is inhibited 184. This is probably 
due to reduced ROS expression109, a possibility illustrated by the report that systemic 
oxidative stress in asphyxiated neonates is attenuated when they are treated with 
TH185. A reduction of circulating WBCs during TH is common in neonatal animal 
models, and leukopenia is observed in neonates during TH111. A significant drop in 
WBCs with its subclasses during TH, with the nadir coming after rewarming, 
together with decreased IL-6, IL-10, and IL-8 was demonstrated in the studies 
reported in paper III. This drop is possibly associated with a better outcome after 12 
months, as recently demonstrated by Jenkins et al.113. Although the Jenkins et al. 
paper employed TH for only 48 hours before rewarming, babies with a prolonged low 
WBC count had a worse outcome (death or severe neurodevelopmental problems), 
implying that an immune paresis occurred in the bone marrow.  
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The increasing body of evidence that TH has a dampening effect on WBCs and the 
immune response suggests that crosstalk occurs between released chemokines and 
leukocytes, although the purpose of this is not obvious presently. Although the 
patients in the studies reported in paper III did not have documented septicaemia or a 
significantly elevated C-reactive protein (CRP), a hypothermic-dampened immune 
system may bring about a worse outcome, as demonstrated in animal models and in 
TH applied in the presence of infection186. This justifies using prophylactic antibiotics 
during TH. A negative correlation between IL-1α and MAP could possibly explain a 
lower COPif due to a TH-related increase in post-capillary resistance. This resistance 
















6. General conclusions 
= Reproducible measurements of colloid osmotic pressure (COP) from 
interstitial fluid (IF) are achievable using the wick method (paper I). 
= Water content of implanted wicks does not influence interstitial COP when 
using wick-implantation times between 60 and 120 minutes (paper I).  
= Use of the wick method influences the tissue space minimally, causing 
negligible protein contamination of the wicks (paper I).  
= Pretreatment of the skin with topical anaesthetics does not influence interstitial 
COP harvested from dry or wet wicks with different implantation times, and 
causes less discomfort during a procedure that some find distressing, like wick 
implantation (paper I). 
= Plasma and interstitial COP values measured in children are within the range 
of reported values for adults (paper II).  
= Increasing age from 2 to 10 years is associated with a rise in COP, assessed in 
both plasma and interstitial fluid (paper II).  
= Wick implantation times between 60 and 90 minutes in children do not alter 
interstitial COP (paper II). 
= An increased difference between plasma and interstitial COP is observed in 
children from 2 to 7 years of age, and possibly contributes to increased IF 
absorption (paper II).  
= Resting in supine position for at least one hour before the wick procedure is 
performed does not change the measured interstitial COP in children. This 
observation is the opposite of what happens in adults and may be due to 
different orthostatic effects on IF filtration in adults that are absent in children 
(paper II). 
= Optimal implantation time for wet wicks is between 60 and 90 minutes, in 
accordance with previous recommendations (papers I and II).  
= Plasma and interstitial COP measured in neonates during therapeutic 
hypothermia (TH) is markedly reduced due to hypoxic ischemic 
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encephalopathy. This is in contrast to that observed in healthy neonates and 
children (paper III).  
= An increased IL-1α in the interstitium of skin and a concomitantly reduced 
MAP during TH for neonatal asphyxia suggest that local endothelial tissue 
















7. Implications and future perspectives 
Although COP assessed in IF and plasma in healthy adults corresponds to that in 
children aged between 2 and 10 years, there is still a gap in information on 
characteristics of IF in children from birth to early childhood. The transition of TBW 
percentage from birth to the first months of infancy encompasses unknown alterations 
in hydrostatic adaptation, together with COP on both sides of the capillary. Although 
sampling of IF is less painful after application of topical EMLA cream in adults, the 
method needs validation in the paediatric population before further studies are 
conducted.  
The growing body of knowledge about glycocalyx structure, function, and 
significance on COP highlights the importance of developing models for calculating 
and analysing IF for determining the COP of the glycocalyx.  
Because small alterations in the pressure gradient over the capillary membrane may 
cause substantial fluid shifts, the implications of this shift, vis-à-vis COP, in both 
health and disease need to be addressed. Also, the influence of crystalloids, colloids, 
and diuretics need to be addressed, especially in the paediatric population.  
Locally produced cytokines have not, to our knowledge, been studied before in 
neonates. Gaining a better understanding of tissue cytokine production may present 
an opportunity for modulating inflammation and suggest possible treatment 
approaches as an adjuvant therapy during TH in neonates. 
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